Next Article in Journal
The Conundrum of Spinal Metastases—A Review of Current Management
Previous Article in Journal
Selective Appendectomy in Patients Undergoing Minimally Invasive Surgery for Endometriosis: A Retrospective Cohort Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Air Pollution, Kidney Injury, and Green Nephrology—Thinking About Its Association and Causation

by
Sławomir Jerzy Małyszko
1,†,
Adam Gryko
2,†,
Jolanta Małyszko
3,*,
Zuzanna Jakubowska
3,
Dominika Musiałowska
4,
Anna Fabiańska
3 and
Łukasz Kuźma
2
1
Department of Physiology and Pathophysiology, Medical University of Warsaw, 02-091 Warsaw, Poland
2
Department of Invasive Cardiology, Medical University of Bialystok, M. Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland
3
Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland
4
Department of Cardiology, Lipidology and Internal Diseases, Medical University of Bialystok, Żurawia 14, 15-569 Bialystok, Poland; dominika.musialowska@umb.edu.pl
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2025, 14(20), 7278; https://doi.org/10.3390/jcm14207278
Submission received: 6 September 2025 / Revised: 29 September 2025 / Accepted: 6 October 2025 / Published: 15 October 2025
(This article belongs to the Section Nephrology & Urology)

Abstract

Air pollution is associated with many adverse health outcomes, especially regarding the cardiovascular and pulmonary systems. Recently, the attention of researchers has been attracted to the influence of air pollution on renal function; therefore, more and more data are emerging on the effects of air pollution on kidney diseases. Kidney diseases, especially chronic kidney disease (CKD), are a significant health problem around the world. It is estimated that CKD affects 9.1% of the world’s population, and its prevalence is constantly increasing. CKD is the direct cause of 1.2 million deaths annually. Available experimental models show the relationship between exposure to air pollutants and kidney function. Geographical differences may have an impact on the effect of air pollution on the prevalence of kidney disease. In the majority of studies, long-term exposure to particulate matter-PM2.5 is associated with an increased risk of CKD progression to kidney replacement therapy. There is far less evidence on the effect of short-term exposure to air pollution on renal function. Data on the associations between acute kidney injury/acute kidney disease and cardio-kidney metabolic syndrome are even more limited than those on chronic kidney disease. In a mouse model of acute kidney injury, exposure to PM2.5 increased susceptibility to chronic kidney disease. In human studies, air pollution was associated with increased risk for first hospital admission for acute kidney injury and mortality due to acute kidney injury. In this review, we would like to summarize the state of knowledge, assessing the influence of air pollution on kidney function. We tried to assess critical associations between air pollution and kidney disease, as well as the translation of these findings in clinical practice. In addition, we aimed to tie green nephrology to air pollution and kidney disease and stressed the paramount role of prevention of kidney disease as the most important aim.

1. Introduction

Air pollution is associated with many adverse health outcomes, especially regarding the cardiovascular and pulmonary systems [1,2,3,4,5,6,7,8,9,10,11]. The first scientific statement concerning the influence of air pollution on the incidence of cardiovascular diseases was published in 2004. The expert panel noticed that short-term and long-term exposure to elevated particulate matter influences cardiovascular mortality and morbidity [12]. In 2005, the World Health Organization published the first air quality guidelines, which were updated in 2022 [13,14]. According to the European Environment Agency in 2022, 239,000 premature deaths were recorded in Europe from chronic exposure to fine particulate matter, of which 48,000 were from chronic nitrogen dioxide exposure, and 70,000 were from acute ozone exposure [15].
Polish smog is a specific type of air pollution present in Eastern Poland, which may cause particularly adverse cardiovascular effects. ED-PARTICLE study showed a strong association between air pollution and ischemic stroke, cause-specific mortality in women and the elderly, acute coronary syndromes, atrial fibrillation, and mortality [16,17,18,19,20,21]. Air pollutants affect different organs in many ways, depending on their aerodynamic size. Through the respiratory system, they target different anatomical locations, including the kidneys, among others. To classify air pollutants, particles were divided depending on their aerodynamic size, as thoracic particles (≤10 µm)—PM10, fine fraction (≤2.5 µm)—PM2.5, coarse fraction (2.5–10 µm)—PM2.5–10, and ultrafine particles (<0.1 µm)—UFP [22]. Inhaled particles lead to the release of inflammatory mediators, which result in pulmonary and systemic inflammation [23]. Ambient air pollutants provoke disturbances in the autonomic nervous system and provoke oxidative stress [23,24,25,26]. Airborne particulates, via pulmonary epithelium, may enter the blood circulation and affect tissues directly [27]. Moreover, increased PM2.5 concentration relates to hypertension [28,29], and exposure to air pollutants results in a higher risk of diabetes [30,31,32], well-known risk factors of kidney diseases. Chronic kidney disease (CKD), an independent risk factor for cardiovascular disease, is still a huge problem in healthcare worldwide. The median estimated prevalence of CKD in all stages is 9.1% and is still rising [33,34]. It should be emphasized that CKD was the cause of 1.2 million deaths [35]. Moreover, CKD is also recognized as an independent risk factor for the leading cause of deaths globally—cardiovascular diseases [36]—as 1.4 million cardiovascular deaths were attributable to kidney diseases in 2017. It is of great importance to prevent, diagnose early, and treat CKD properly.
In addition to well-known risk factors such as diabetes and hypertension, recently, the attention of researchers has focused on the influence of air pollution on renal function.
Recently, more data have emerged on the effects of air pollution on kidney diseases [37,38,39]. In this review, we would like to present the knowledge about the influence of air pollution on kidney function.
The review was conducted between October 2024 and June 2025. The literature review included publications on research from January 2015 to June 2025. Relevant articles were identified by two authors searching PubMed, Scopus, Web of Science, Embase, and Cochrane Library databases using advanced search and keywords: [[air pollution] OR [air pollutants]] AND [acute kidney injury] OR [acute kidney disease] OR [chronic kidney disease]. The articles were reviewed in three stages by two researchers. We identified 586 entries, 305 of which were rejected because of duplication by automated tools. In the second stage, 180 studies were rejected after reviewing their abstracts due to an ineligible study group or an unsuitable aim of the study. Conference reports and overviews were also excluded. Finally, 101 papers were selected in the third phase. Single case reports did not qualify for the review.

2. Air Pollution and Kidney Disease

2.1. Experimental Studies

Available experimental data show the relationship between exposure to air pollutants and kidney function. In 2009, Nemmar et al. published the results of the first experimental study investigating in vivo the aggravating effect of pulmonary exposure to diesel exhaust particles (DEPs), in an animal model of acute kidney failure induced by cisplatin [40]. DEPs are the major contributors to PM2.5 and ultrafine particles in cities [22]. Six days after the single injection of cisplatin, rats were intratracheally instilled with DEPs or saline (control group). The study group concluded that DEP exposure worsened the renal, pulmonary, and systemic damage in the cisplatin-induced acute renal failure model after 24-h observation [41]. Also, repeated exposure to DEPs in rats with cisplatin-induced kidney damage aggravated cisplatin-induced nephrotoxicity [40].
Also, in 2016, Nemmar et al. [42] published their next experimental study evaluating prolonged exposure to DEPs on mice with chronic renal failure. Kidney failure was induced by adenine added into the feed for 4 weeks, while the DEPs or saline (control) were intratracheally instilled seven times (every 4 days for 4 weeks). They observed aggravated renal oxidative stress and inflammation, as DNA damage occurred after exposure to DEPs in mice with adenine-induced kidney damage [42].
Al Suleimani et al. observed in an animal model that exacerbated vascular damage in rats with adenine-induced chronic kidney failure after exposure to DEPs, if compared to rats that did not undergo intratracheal DEP administration [43].
Waly et al. [44] conducted an in vitro study using human embryonic kidney cells (HEK-293). The study group analyzed the DEP exposure and cisplatin-induced oxidative stress in HEK-293 cells. DEPs augmented the cisplatin-induced HEK-293 cells’ toxic damage. Interestingly, DEPs significantly reduced cysteine uptake. Curcumin, which deserves attention, presented significant protection against DEPs and cisplatin-induced toxicity [44].
Recently, in wild-type C57BL/6J mice exposed to either HEPA-filtered air or clean ultrafine carbonaceous particles (UFPC, 450 μg/m3) during the prenatal (gestational day 8–9 + 16–17) and/or postnatal (PND 4–7 + 10–13) phase, changes in kidney morphology were observed. The most prominent findings were the alteration of overall areas of the cortex and medulla together, mainly smaller cortical and larger medullary areas. This was associated with alterations in tubular and interstitial structures, mainly with lower tubular area and altered tubular shapes, together with reduced solidity and circularity. These changes may potentially increase kidney vulnerability to damage. It should be stressed that further studies to assess the long-term impact of environmental pollutants on kidney health are of paramount importance [45]. The proposed mechanism of the effects of air pollution on kidney injury is given in Figure 1.

2.2. Air Pollution and Kidney Function—Chronic Kidney Disease

Bowe et al. [46] performed a huge prospective observational cohort study consisting of 2,482,737 United States veterans and linked the database with the Environmental Protection Agency database. The study group noticed that a 10-µg/m3 increment in PM2.5 annual average concentration was associated with increased risk of the occurrence of the following: eGFR lower than 60 mL/min per 1.73 m2, chronic kidney disease, eGFR decline ≥ 30%, and end-stage renal disease (ESRD). Subsequently, Bowe et al. [47] also observed that increased risk of CKD, eGFR decline, and ESRD occurrence was also associated with higher annual concentration of PM10, nitrogen dioxide (NO2), and carbon monoxide (CO).
It was observed, in another study involving 669 US veterans [48], that a 2.1 µg/m3 higher 1-year PM2.5 concentration was associated with 1.87 mL/min/1.73 m2 lower eGFR and an additional annual decrease in eGFR of 0.6 mL/min/1.73 m2.
In another study from a US Medicare population of 61,097,767 (all beneficiaries aged 65 years or older), Lee et al. [49] assessed the associations between air pollution and first hospital admission for kidney and total urinary system diseases. They found that positive associations between PM2.5 and kidney outcomes persisted at concentrations below national health-based air quality standards.
In a recent study from the USA, Ma et al. [50] investigated the association between long-term exposure to wildland fire smoke PM2.5 and nonaccidental mortality and mortality from a wide range of specific causes in all 3108 counties in the contiguous United States, from 2007 to 2020. They reported that long-term wildland fire smoke PM2.5 exposure was associated with mortality from various diseases, including chronic kidney disease, cardiovascular diseases, diabetes, etc. In addition, higher mortality was observed in people aged 65 and above. Moreover, Do and Zhang [51] combined the 2023 Centers for Disease Control and Prevention health surveys, criteria air pollutants, and socioeconomic status at the census tract level, and examined the impact of air pollution on human health across the entire U.S. They found that ozone (O3) was highly related to the prevalence of cancer and kidney disease, whereas PM2.5 was associated with most diseases. They also stressed that minorities and low-income groups across the U.S, exposed to higher levels of PM2.5, were more prone to greater health risks, including kidney disease, together with high blood pressure, diabetes, and mental and physical health. Dillion et al. [52], using a random sample of North Carolina’s electronic healthcare records (EHRs) from 2004 to 2016, concluded that one-year average PM2.5 was associated with reduced eGFRcr, while O3 and NO2 were negatively associated. On the other hand, Adgate et al. [53] reported that airborne particulate matter exposure in male sugarcane workers appeared to be a risk for chronic kidney disease in Guatemala. Slightly different results were obtained by Yang et al. [54]. In this Taiwanese study, there was no significant association between PM2.5 and the prevalence of CKD and eGFR, but increase in average 1-year PM10 and PM coarse concentration was associated with a lower eGFR (−0.69 mL/min/1.73 m2 for PM10 and −1.07 mL/min/1.73 m2 for PM coarse) and a higher prevalence of CKD (1.15 for PM10 and 1.26 for PM coarse). In another Taiwanese study, 6628 adult patients with CKD were recruited from the Advanced CKD Program in Taiwan between 2003 and 2015. Recently, Chen et al. [55] studied long-term exposure to PM2.5 and PM10 using high-resolution satellite-based data from the China High Air Pollutants (CHAP) dataset on impact on IgA nephropathy (IgAN). They found that among 1768 biopsy confirmed IgAN patients, 209 of them progressed to ESRD over a median follow-up of 3.63 years. They concluded that higher exposure to both PM2.5 and PM10 was significantly associated with an increased risk of progression to ESRD, with hazard ratios of 1.62 and 1.36 per 10 µg/m3 increase, respectively.
In the most recent study from Taiwan, Wu et al. [56] assessed exposure to air pollution in relation to kidney function decline, measured by ≥30% or ≥40% reductions in eGFR. They designed the study as a nested case–control study using data from the Adult Preventive Healthcare Services database and National Health Insurance claims (2016–2021) with 1-year, 2-year, 3-year, and 5-year follow-up prior to the outcome occurrence. Their cohort consisted of 871,295 health checkup subjects. They assessed air pollution exposure to six pollutants (PM2.5, PM10, NO2, SO2, CO, and O3) in relation to eGFR decline using land-use regression combined with machine learning algorithms. They found that higher concentrations of all six pollutants were associated with significant increases in the odds of kidney function decline, with CO and PM2.5 having the strongest associations with decline in eGFR. The associations were strongest in the 1- and 2-year period relative to 3- and 5-year exposure time. In another study from Taiwan on 9,256,945 participants from Taiwan’s National Health Insurance Research Database (2006 and 2021), Li et al. [57] showed that long-term exposure to ozone was significantly associated with the incidence of CKD, hypertension, and diabetes, as well as transition to multimorbidity and mortality.
In many Chinese studies [58,59,60,61,62,63,64,65,66], there are correlations between air pollution and chronic kidney disease. In a recent cohort study of 47,204 subjects, a 10 μg/m3 increase in PM1 (air particles with a diameter ≤ 1 μm) was associated with an increased risk of albuminuria and CKD. These results highlight the critical need for implementing air pollution control strategies to alleviate the burden of CKD [58]. In the most recent comprehensive systemic review and meta-analysis conducted by Li et al [67], 32 studies with 3,022,895 participants were included. They found that long-term exposures to PM2.5, PM10, and NO2 were linked to decreased eGFR. In addition, long-term exposure to PM2.5 (per 10 μg/m3) was also linked to elevated serum creatinine and uric acid. Moreover, short-term exposure to PM2.5 (per 10 μg/m3) was also linked to lower eGFR and higher blood urea nitrogen. Based on these data on more than 3 million participants, authors stressed the potential detrimental impacts of ambient air pollution on kidney function.
The most recent study from China [68] investigated the link between indoor air pollution from non-clean fuels used in households and kidney function decline, particularly in a cohort of 4207 middle-aged and elderly individuals in China. Kidney functions were assessed through eGFR (using serum creatinine and cystatin C), and then logistic regression models were used to examine the link between the use of household solid fuel for cooking and the risk of rapid kidney decline and CKD. Tang et al. [68] reported that common use of solid fuel was associated with a higher risk of both rapid kidney decline and CKD. In addition, solid fuels used only for cooking were associated with a higher risk of CKD (OR 1.70; 95% CI: 1.07–2.70). More importantly, switching from solid to clean fuels for cooking was not associated with significant changes in kidney function. The authors also stressed that when solid fuel was used for cooking the risk factors for CKD included lower education, non-smoking status, and being married/cohabiting, whereas when solid fuel was used for heating, risk factors for rapid kidney decline and CKD included being female, having a lower education, being a non-smoker or non-drinker, and being married or cohabiting, as well as having history of gastrointestinal diseases. Hypertension was a risk factor for both rapid kidney decline and CKD with solid fuel use. It is of interest that inhabitants of concrete or steel multi-story buildings using solid fuels had the highest risks of rapid kidney decline and CKD, similar to those in homes smaller than 120 square meters.
Similar data were presented by Thai researchers [69] investigating the spatial–temporal association between PM2.5 and its components (organic carbon, black carbon, dust, sulfate, and sea salt) and CKD mortality in Thailand from 2012 to 2021. They found that each 1 µg/m3 increase in PM2.5, black carbon, dust, sulfate, and organic carbon was significantly associated with increased CKD mortality across 77 provinces. Moreover, they also reported that the geographical difference with the highest death rate was in the Northeast region of Thailand. Air pollution was also a risk factor for renal function deterioration, as defined as sustained eGFR of less than 60 mL/min per 1.73 m2 in 1394 South Korean patients with primary glomerulonephritis followed for a mean of 5.1 years [70].
In a recent retrospective study from South Korea, Kwon et al. [71] assessed the effect of air pollutants on the progression of end-stage kidney disease (primary endpoint), as well as on mortality (secondary composite outcome consisting of ESRD and death), in patients with diabetic kidney disease. They pay special attention to medication use. They used the nation-wide forecasted ultra-high-resolution air pollutant data [2.5-μm particulate matter (PM2.5), 10-μm particulate matter (PM10), nitrogen dioxide (NO2), carbon monoxide (CO)] obtained from the Ai-Machine learning Statistics Collaborative Research Ensemble for Air pollution, Temperature, and all types of Environmental exposures (AiMS-CREATE). They updated ambient air pollution data and prescriptions for medication on a monthly basis as time-varying variables in multivariable time-dependent Cox analyses. Their cohort consisted of 9482 patients, followed for a median of 9 years for ESRD and 11 years for composite outcome (ESRD and death). They found that 20.6% of the studied patients progressed to ESRD and 46.7% experienced composite outcomes. They also noted that all four air pollutant concentrations (PM2.5, PM10, NO2, and CO) significantly decreased, with CO showing the most pronounced decline during the follow-up period. In addition, NO2 exposure increased ESRD progression risk but was not associated with composite outcomes. Exposure to PM2.5 was independently associated with an increased risk of ESRD progression and composite outcomes in patients with DKD, even after comprehensive adjustment of medication used, i.e., renin–angiotensin system blockers. In another study from South Korea, Beak and Yoon [72] analyzed a nationwide sample of 69,066 Korean adults, exploring the association between exposure to air pollutant mixture (PM10, PM2.5, SO2, NO2, CO, and O3) and renal function expressed as eGFR. They found a negative association between the pollutant mixture and eGFR in the studied population.
Using the Korean National Health Insurance Service and Statistics Korea, Choi et al. [73] in a retrospective cohort study including 2,880,265 individuals (41,501,709 person-years), of which 176,410 were people with disabilities (2,011,231 person-years), analyzed the association between long-term exposure to ambient fine particulate matter (PM2.5) and mortality risk in PWD, considering disability type and severity. Patients with kidney impairment showed a significant association between PM2.5 and all-cause mortality.
However, geographical differences may have an impact on the effect of air pollution on kidney disease prevalence. In Japan, in Ibaraki prefecture, Nagai et al. [74] studied 77,770 men and women with estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 who participated in annual community-based health checkups starting in 1993 at 40–75 years old and were followed up through to December 2020. In this first Japanese study, elevated PM2.5 was not a significant risk factor for incident CKD.
The first large European study investigating the medium- and short-term impact of air pollutants on kidney function was published in 2021 by Kuzma et al. [75]. A group of 3554 patients was included in the retrospective study. The air pollution data were obtained from the Voivodeship Inspectorate for Environmental Protection. The increase in the annual concentration of PM2.5 and NO2 was associated with an increased risk of CKD (HR for IQR increase = 1.07 for PM2.5 and 1.05 for NO2). In the same study, it was observed that increased weekly PM2.5 concentration was associated with a reduction in expected eGFR (2% for IQR).
Hamroun et al. [76], in the French REIN registry nationwide cohort study, included 90,373 adult kidney failure patients, initiating maintenance dialysis between 2012 and 2020, and investigated the association of multiple exposures to air pollutants PM2.5, PM10, and NO2 with all-cause and cause-specific death in dialysis patients. They found that long-term multiple air pollutant exposure was associated with all-cause and cause-specific mortality in the dialysis population.
Cesaroni et al. [77] also performed a registry-based study on the association of long-term exposure to nitrogen dioxide (NO2), fine particulate matter (PM2.5), black carbon (BC), and ozone (O3), with end-stage kidney disease incidence in two large population-based European cohorts, i.e., the Austrian Vorarlberg Health Monitoring and Promotion Program (VHM&PP, 136,823 individuals) and the Italian Rome Longitudinal Study (RoLS, 1,939,461 individuals). Interestingly, in the Austrian cohort, no evidence of an association between PM2.5 or O3 and end-stage kidney disease was observed, whereas in the Italian cohort, PM2.5 exposure was associated with the incidence of end-stage kidney disease. Kadelbach P et al. [78], in the European multicenter ELAPSE study on 289,564 persons, followed for 20.4 years, found positive associations between exposure to PM2.5- and CKD-related mortality and inverse associations for ozone. This study included only Western European cohorts with at least 10 cases of CKD-associated mortality (Diet, Cancer, and Health cohort from Denmark [DCH], Danish Nurse Cohort [DNC-1993, the prospective sub-cohort of Dutch European Investigation into Cancer and Nutrition [EPIC_NL-Prospect], Etude Epidémiologique auprès de femmes de la Mutuelle Générale de l‘Education Nationale [E3N from France, and Vorarlberg Health Monitoring and Prevention Programme] VHM&PP from Austria). However, after exclusion of the largest sub-cohort contributing 226 cases from Austria, associations became null. There is far less evidence on the effect of short-term exposure to air pollution on renal function.
He et al. [79] observed in multivariable analysis that a higher level of NO2 was associated with hospital-acquired acute kidney injury in the Chinese population. The association was present in subgroups depending on age, gender, eGFR, severity of acute kidney injury, and also needed intensive care procedures.
Table 1 and Table 2 show the main outcomes of the published studies on short-term (Table 1 and long-term (Table 2) exposure to air pollutants, presented in ascending order from the least to the most recent.

2.3. Air Pollution and Acute Kidney Injury/Acute Kidney Disease

Acute kidney injury (AKI), defined as what was previously called acute renal failure (ARF), is a sudden decrease in kidney function that develops within 7 days, as shown by an increase in serum creatinine or a decrease in urine output, or both [133]. The term acute kidney disease and disorder, abbreviated to acute kidney disease (AKD), has been introduced as an important construct to address this. AKD is defined by abnormalities of kidney function and/or structure with implications for health and with a duration of ≤3 months [134]. Data on associations between acute kidney injury and acute kidney disease are even more limited than those for chronic kidney disease. In an animal model, mice were exposed to urban PM2.5 or filtered air for 12 weeks before ischemia–reperfusion injury [135]. Mice showed signs of reduced glomerular filtration, impaired urine concentration ability, and significant tubular damage. PM2.5 appears to play a role in sensitizing proximal tubular epithelial cells to ischemia–reperfusion-induced damage, suggesting a plausible association between PM2.5 exposure and heightened susceptibility to chronic kidney disease in individuals experiencing acute kidney injury. Similar data were obtained by Hou et al. [136] who assessed the effects of PM2.5 exposure in C57BL/6N mice (n = 8). They found signs of oxidative stress, autophagy, and pyroptosis. In addition, in vitro studies using HK-2 cells stimulated by PM2.5-induced tubulopathy revealed increased reactive oxygen species (ROS) generation, as well as activation of pyroptosis and autophagy.
Bi et al. [81] investigated associations between short-term exposure to PM2.5, major PM2.5 components [elemental carbon (EC), organic carbon (OC), sulfate, and nitrate], and gaseous co-pollutants (O3, CO, SO2, NO2, and NOx) and emergency department visits for kidney diseases during 2002–2008 in Atlanta, Georgia, USA. In addition, Lee et al. [137] studied 61,300,754 beneficiaries enrolled in Medicare Part A fee-for-service (FFS) who were older than 65 years of age and residents of the continental United States from the years 2000 to 2016. In this nationwide population-based longitudinal cohort, exposure to PM2.5, NO2, and O3 was associated with an increased risk of first hospital admission for AKI. More importantly, this association persisted even at low concentrations of air pollution estimated by the National Ambient Air Quality Standard.
He et al. [79] selected a cohort of 11,293 AKI cases from the Epidemiology of AKI in Chinese Hospitalized patients, in which the onset date could be unambiguously determined. In the multivariable analysis, NO2 was the sole pollutant associated with the risk of AKI (p < 0.001), with a linear relationship to hospital-acquired AKI. Acute renal failure was positively related to 8-day exposure to organic carbon [1.034 (1.005, 1.064)], elemental carbon [1.032 (1.002, 1.063)], nitrate [1.032 (0.996, 1.069)], and PM2.5 [1.026 (0.997, 1.057)]. Similarly, Fang et al. [80] reported that PM2.5 was inversely associated with eGFR in older Chinese individuals monitored for 72 h.
In South Korea, Min et al. [138] estimated the association between short-term exposure to air pollution (fine particulate matter ≤ 2.5 μm [PM2.5] and ozone [O3]) and incident AKI by comorbid diseases using the Korea National Health Information Database (NHID). They identified 160,390 incident AKI cases. They found that short-term air pollution exposure to PM2.5 was associated with emergency department visits due to AKI. Furthermore, Min et al. [139] investigated the association between short-term exposure to air pollution particulate matter ≤ 2.5 μm (PM2.5), ozone (O3), and nitrogen dioxide (NO2) and AKI-related mortality using a multi-country dataset. They identified 41,379 AKI-related deaths in 136 locations in six countries (Canada, Japan, Portugal, South Korea, Taiwan, and the UK) during 1987–2018.
Their study showed that the risk appeared immediately on the day of exposure to air pollution, gradually decreased, and then increased again, reaching the peak approximately 20 days after exposure to PM2.5 and O3 [139].
The prospective cohort analysis included 414,885 UK Biobank (UKB) participants who did not exhibit AKI at the study’s outset. Liu et al. [140] assessed the association between prolonged exposure to air pollutants (particulate matter with diameters of 2.5 μm or less (PM2.5), between 2.5 and 10 μm (PM2.5–10), and 10 μm or less (PM10), along with nitrogen dioxide (NO2) and nitrogen oxides (NOx)) and the risk of AKI and AKI-related death. They also adjusted for potential confounders such as sex, age, ethnicity, education, income, lifestyle factors, and relevant clinical covariates. During follow-up lasting up to 11.7 years, 14,983 cases of AKI and 326 cases of AKI-related death were diagnosed. In addition, they showed that individuals from the higher quartile exposed to higher levels of PM2.5, PM2.5–10, PM10, NO2, and NOx had a significantly higher risk of developing AKI and AKI-related death relative to subjects from the lowest quartile (all p < 0.05). The relationships between PM2.5, PM2.5–10, PM10, NO2, NOx, and the risk of AKI showed a significant departure from linearity (Pfor non-linearity < 0.05), whereas the relationships between PM2.5, NO2, NOx, and the risk of AKI-related death did not exhibit a significant departure from linearity (Pfor non-linearity > 0.05) on restricted cubic splines–RCS curves.
In 2022, Lee et al. [83] published an analysis estimating the number of emergency room visits because of the deterioration of kidney function due to short-term exposure to air pollutants (particulate matter ≤ 10 µm, ozone, carbon monoxide, and sulfur dioxide). The highest impact of the increased number of visits to the ER because of AKI in South Korea in the years 2003–2013 was associated with higher ozone concentration. The authors concluded that stricter air quality standards may benefit patients with kidney diseases [83]. In the Table 3 summary of the major studies on air pollution effects on acute kidney injury/acute kidney disease is presented.

2.4. Air Pollution and Cardiovascular-Renal-Metabolic Syndrome

As cardiovascular-renal-metabolic (CKM) syndrome substantially elevates the risk of cardiovascular disease (CVD), Zhao et al. [143] assessed, in a nationwide prospective cohort study, the associations between environmental air pollution and long-term exposure to different sizes of particulate matter (PM1, PM2.5, and PM10) and CVD risk across the four stages of CKM syndrome in a median follow-up of 7 years. They used data from the China Health and Retirement Longitudinal Study (CHARLS, 2011–2018), which included 5824 participants aged 45 years or older with stage 4 CKM according to American Heart Association guidelines. They assessed annual average concentrations of PM1, PM2.5, and PM10 in order to estimate individual exposure and then to assess the burden of air pollution on CVD. They found that increased CVD risk was significantly associated with the highest exposure to PM2.5 (HR = 2.31, 95% CI: 2.00–2.66) and rose progressively with CKM stage, being the highest in stage 3 for PM1 (HR = 3.32, 95% CI: 2.24–4.92). Interestingly, patients with CKD had an attenuated association, probably due to the use of nephroprotective drugs. In another study, Shi et al. [144] studied the impact of air pollution on CKM progression in 44,369 (UK Biobank) and 4847 Yinzhou cohort patients (China). The authors found that in the Chinese cohort, there was an association between air pollution and CKM stage progression, whereas in the UK cohort, an association was significant for CKM-related death. Paradoxically, a higher risk for CVD onset and death was reported for non-overweight individuals when exposed to air pollution relative to their overweight counterparts. The authors also underlined the distinct manifestation between these two cohorts and advocated for putting in an effort to reduce air pollution, especially regarding particulate matter in China.

3. Pesticides and Acute Kidney Injury and/or Chronic Kidney Disease

Nowadays, evidence is growing on the possible associations between chronic pesticide exposure and adverse health effects, including kidney injury [145,146,147]. Pesticides, along with pollutants, that pollute working environments are xenobiotics, i.e., synthetic substances present in micropollutant concentrations and high concentrations in living organisms as well as in the environment [148]. According to Olowu et al. [149], they are responsible for up to 18% of cases of acute kidney injury in the pediatric population. Glyphosate exposure is linked to the elevated levels of kidney injury molecules in children [150]. Jayasumana et al. [151] demonstrated a link between exposure to xenobiotics, such as organophosphates, paraquat, 2-methyl-4-chlorophenoxyacetic acid (MCPA), glyphosate, bispyribac, carbofuran, mancozeb, and others, and acute renal injury in Sri Lankan farmers.
Detected glyphosate in over >90 of the samples obtained from inhabitants of a rural village in Southern Brazil exposed to pesticide drift from the spraying of neighboring crops [152]. It reflects the widespread contamination of fruits, vegetables, or grains by glyphosate [153]. In two other Brazilian regions with pesticide-intensive use, higher mortality due to AKI was observed, mainly in younger agricultural workers, females, and in the southern region [154,155].
Khacha-Ananda et al. [156] recently reported that farmers who regularly sprayed glyphosate-surfactant herbicides were at high risk of exposure, potentially causing significant kidney injury. Insecticides such as organophosphates and the pyrethroid group are the most used pesticides in agricultural and domestic settings, with malathion being the most commonly used in the US [157] and relatively less toxic than other pesticides [158]. It was reported that malathion exposure caused acute kidney injury with proteinuria/nephrotic syndrome [159,160]. Wan et al. [161] assessed the association between pesticide exposures and the risk of kidney function loss in 41,847 participants using four waves of the National Health and Nutrition Examination Survey (NHANES). They found that exposure to malathion is linked to evidence of altered kidney function. In the study from Almeria, Southeastern Spain, a major hub of greenhouse agriculture, Lozano-Paniagua et al. [162] found that pesticide exposure in the period of its greater use was associated with subclinical tubular damage, which may lead, in time, to chronic kidney disease.
Acute paraquat exposure leading to acute kidney injury has been known since it was first marketed in the 1960s [163,164,165]. However, data on chronic paraquat exposure and kidney disease are limited [151,166,167,168,169]. In endemic areas of unknown chronic kidney disease, urinary glyphosate and paraquat were associated with kidney damage in rural farmers [170]. Similarly, Stem et al. [171] found that certain pesticides were significantly elevated in the urine of sugarcane workers with or without kidney function decline in Guatemala. Finally, increasing paraquat exposure was associated with the incidence of end-stage kidney failure [172]

4. Limitations of the Studies

In recent years, there has been growing attention to the effects of air pollution and kidney health. There is evidence that short-term exposure to air pollutants is associated with glomerular filtration rate decline, whereas long-term exposure is related to increased risk of CKD, together with structural damage to kidney tissues. The proposed mechanisms include systemic inflammation, oxidative stress, endothelial dysfunction, and direct nephrotoxicity; however, experimental data are not abundant. In general, data on both short- and long-term effects of air pollution are heterogeneous. There are many cross-sectional and retrospective studies, while prospective studies are very limited, making translation into the real world rather doubtful and challenging. In addition, findings are also not consistent. Most available studies are from Asia and the United States, while data from Europe, Africa, South America, and the Middle East are limited. Future studies in these populations are warranted to assess whether the observed associations are consistent across different ethnic, environmental, and socioeconomic backgrounds. As data from some parts of the world, i.e., South America, Australia, Africa, the Middle East, or even some parts of Europe, are limited or lacking, it is rather a challenge to draw final conclusions regarding the effect of air pollution on kidney health, as well as to propose preventive measures. It appears that heat stress is also an important risk factor for kidney disease, as well, and pollution coming from heating in the winter is even more dangerous. In addition, there is no data available as to precisely when exposure to various air pollutants was assessed in retrospective studies; therefore, it is difficult to estimate the real toxic effect, as concentrations are dependent upon many different factors, including changeable weather conditions, wind, type of heating, traffic conditions, etc.
Therefore, more data are needed to assess more thoroughly and precisely the association between air pollution and kidney health.

5. Green Nephrology in Relation to Kidney Disease and Air Pollution

In 2018, an editorial by members of the Executive Council of the European Renal Association—European Dialysis and Transplant Association (ERA-EDTA) was published in Nephrology Dialysis Transplantation as a call for action to medical professionals—both as individuals and as representatives of professional organizations—to contribute to efforts aimed at establishing a ‘greener’ healthcare sector [145]. The key message of the Lancet Countdown was cited in this document [146], particularly Indicator 5.2, which emphasized the importance of research in improving our understanding of the links between climate change and health. On the one hand, it is important to raise awareness among medical professionals of the different components that contribute to the healthcare sector’s carbon footprint. On the other hand, we need to emphasize the links between greenhouse gas emissions, air pollution (especially fine particulate matter, PM2.5, sulfur dioxide [SO2], and nitrogen dioxide [NO2]), and environmental disorders, including kidney disease. Subsequently, an advocacy article by the European Kidney Health Alliance [147] explored the bidirectional relationship between climate change, kidney health, and the environmental impact of kidney care. The authors discussed how the European Green Deal may offer real potential for supporting and galvanizing urgent environmental changes. They also highlighted that exposure to PM2.5, SO2, and NO2—primarily released from fossil fuel combustion—is associated with an increased risk of kidney disease [147]. Their paper underscored the link between air pollution and the rationale for promoting green nephrology. They further emphasized that waste disposal is expensive, with landfills contributing to environmental contamination, incineration both polluting and emitting greenhouse gases, and dialysis therapies themselves consuming large amounts of water and energy [173]. The Italian Society of Nephrology subsequently proposed several approaches to prevent the onset and slow the progression of kidney disease [174]. These include promoting healthier lifestyle choices with added ecological benefits—such as reducing the consumption of red and ultra-processed foods—as well as supporting organic farming and local products, which lower fuel use and pollutant emissions. Very recently, van Vredendaal et al. [175] pointed out the strong consensus among different stakeholders in the kidney health domain on the need for action to better prevent chronic kidney disease, emphasizing the crucial role of the European Union (EU) in providing legislative and financial frameworks to accelerate the transition toward sustainable healthcare in line with the European Green Deal.

6. Conclusions

Kidney diseases, especially chronic kidney disease and its complications, pose a global health problem. The literature presented above suggests that air pollution could be considered a risk factor for acute kidney injury and acute kidney disease, both entities promoting the development of chronic kidney disease. Dialysis patients represent a particularly vulnerable group with respect to environmental exposures. In a large nationwide cohort from France, long-term exposure to PM2.5, PM10, and NO2 was associated with increased all-cause and cause-specific mortality in patients receiving maintenance dialysis [76]. The susceptibility of this population may be related to chronic systemic inflammation, oxidative stress, and diminished renal reserve, which amplify the toxic effects of pollutants. Although evidence is still limited, these findings suggest that chronic exposure to common air pollutants is likely to contribute substantially to morbidity and mortality among the dialysis population. Several meta-analyses [37,176,177], large European cohorts, and the UK Biobank [77,122] provide evidence that long-term air pollutant exposure is associated with ESRD risk. In addition, there are studies reporting associations with kidney failure requiring replacement therapy [46,97].
Published results highlight the need for implementing air pollution control strategies to alleviate the burden of CKD, a huge burden on the healthcare system. This is also another argument to intensify our efforts to improve air quality. For the first time, we underlined associations between air pollution, kidney health, and green nephrology as a rationale and way to improve outcomes. However, we also must be aware of the limitations of the published heterogeneous data.

Author Contributions

Conceptualization: Ł.K., A.G., S.J.M. and J.M.; methodology: Ł.K. and J.M.; writing—original draft preparation: S.J.M., A.G., Ł.K. and J.M.; writing—review and editing: S.J.M., A.G., Ł.K., J.M., D.M., A.F. and Z.J. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were generated.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Shah, A.S.; Lee, K.K.; McAllister, D.A.; Hunter, A.; Nair, H.; Whiteley, W.; Langrish, J.P.; Newby, D.E.; Mills, N.L. Short-term exposure to air pollution and stroke: Systematic review and meta-analysis. BMJ 2015, 350, h1295. [Google Scholar] [CrossRef]
  2. Miller, K.A.; Siscovick, D.S.; Sheppard, L.; Shepherd, K.; Sullivan, J.H.; Anderson, G.L.; Kaufman, J.D. Long-term exposure to air pollution and incidence of cardiovascular events in women. N. Engl. J. Med. 2007, 356, 447–458. [Google Scholar] [CrossRef]
  3. Talbot, B.; Fletcher, R.A.; Neal, B.; Oshima, M.; Adshead, F.; Moore, K.; McGain, F.; McAlister, S.; Barraclough, K.A.; Knight, J.; et al. The potential for reducing greenhouse gas emissions through disease prevention: A secondary analysis of data from the CREDENCE trial. Lancet Planet Health 2024, 8, e1055–e1064. [Google Scholar] [CrossRef]
  4. Pope, C.A., III; Burnett, R.T.; Thun, M.J.; Calle, E.E.; Krewski, D.; Ito, K.; Thurston, G.D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 287, 1132–1141. [Google Scholar] [CrossRef] [PubMed]
  5. Cesaroni, G.; Forastiere, F.; Stafoggia, M.; Andersen, Z.J.; Badaloni, C.; Beelen, R.; Caracciolo, B.; de Faire, U.; Erbel, R.; Eriksen, K.T.; et al. Long term exposure to ambient air pollution and incidence of acute coronary events: Prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project. BMJ 2014, 348, f7412. [Google Scholar] [CrossRef] [PubMed]
  6. eBioMedicine. Wildfires, smog, and the persistent threat of air pollution to human health. EbioMedicine 2025, 112, 105602. [Google Scholar] [CrossRef]
  7. Fuller, R.; Landrigan, P.J.; Balakrishnan, K.; Bathan, G.; Bose-O’Reilly, S.; Brauer, M.; Caravanos, J.; Chiles, T.; Cohen, A.; Corra, L.; et al. Pollution and health: A progress update. Lancet Planet Health 2022, 6, e535–e547. [Google Scholar] [CrossRef]
  8. Pope, C.A., III; Ezzati, M.; Dockery, D.W. Fine-particulate air pollution and life expectancy in the United States. N. Engl. J. Med. 2009, 360, 376–386. [Google Scholar] [CrossRef]
  9. Lelieveld, J.; Evans, J.S.; Fnais, M.; Giannadaki, D.; Pozzer, A. The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature 2015, 525, 367–371. [Google Scholar] [CrossRef]
  10. Chamberlain, R.C.; Fecht, D.; Davies, B.; Laverty, A.A. Health effects of low emission and congestion charging zones: A systematic review. Lancet Public Health 2023, 8, e559–e574. [Google Scholar] [CrossRef]
  11. Zhang, Q.; Jiang, X.; Tong, D.; Davis, S.J.; Zhao, H.; Geng, G.; Feng, T.; Zheng, B.; Lu, Z.; Streets, D.G.; et al. Transboundary health impacts of transported global air pollution and international trade. Nature 2017, 543, 705–709. [Google Scholar] [CrossRef] [PubMed]
  12. Brook, R.D.; Franklin, B.; Cascio, W.; Hong, Y.; Howard, G.; Lipsett, M.; Luepker, R.; Mittleman, M.; Samet, J.; Smith, S.C., Jr.; et al. Air pollution and cardiovascular disease: A statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004, 109, 2655–2671. [Google Scholar] [CrossRef]
  13. World Health Organization. Air Quality Guidelines: Global Update. Report on a Working Group Meeting, Bonn, Germany. WHO Regional Office for Europe, 2005. Retrieved. Available online: https://www.londonair.org.uk/london/asp/laqnseminar/pdf/Jan2007/WHO_Air_Quality_Guidelines_Update_2005_Dr_Michal_Krzyzanowski_WHO_Regional_Office_for_Europe.pdf (accessed on 5 September 2025).
  14. World Health Organization. WHO Ambient Air Quality Database, 2022 Update: Status Report; World Health Organization: Geneva, Switzerland, 2023; ISBN 978-92-4-004769-3. [Google Scholar]
  15. European Environment Agency. Air Quality in Europe—2022 Report. 2022. Available online: https://www.eea.europa.eu/publications/status-of-air-quality-in-Europe-2022/europes-air-quality-status-2022/world-health-organization-who-air (accessed on 23 March 2025).
  16. Kurasz, A.; Lip, G.Y.H.; Święczkowski, M.; Tomaszuk-Kazberuk, A.; Dobrzycki, S.; Kuźma, Ł. Air quality the risk of acute atrial fibrillation (EP-PARTICLESstudy): Anationwide study in Poland. Eur. J. Prev. Cardiol. 2025, zwaf016. [Google Scholar] [CrossRef] [PubMed]
  17. Dąbrowski, E.J.; Tomaszuk-Kazberuk, A.; Kamiński, J.W.; Strużewska, J.; Dobrzycki, S.; Kuźma, Ł. Association between exposure to air pollution increased ischaemic stroke incidence: Aretrospective population-based cohort study (EP-PARTICLESstudy). Eur. J. Prev. Cardiol. 2025, 32, 276–287. [Google Scholar] [CrossRef]
  18. Kuźma, Ł.; Dąbrowski, E.J.; Kurasz, A.; Święczkowski, M.; Jemielita, P.; Kowalewski, M.; Wańha, W.; Kralisz, P.; Tomaszuk-Kazberuk, A.; Bachórzewska-Gajewska, H.; et al. Effect of air pollution exposure on risk of acute coronary syndromes in Poland: A nationwide population-based study (EP-PARTICLES study). Lancet Reg. Health Eur. 2024, 41, 100910. [Google Scholar] [CrossRef]
  19. Święczkowski, M.; Dobrzycki, S.; Kuźma, Ł. Multi-City Analysis of the Acute Effect of Polish Smog on Cause-Specific Mortality, (EP-PARTICLES study). Int. J. Environ. Res. Public Health 2023, 20, 5566. [Google Scholar] [CrossRef]
  20. Kuźma, Ł.; Roszkowska, S.; Święczkowski, M.; Dąbrowski, E.J.; Kurasz, A.; Wańha, W.; Bachórzewska-Gajewska, H.; Dobrzycki, S. Exposure to air pollution and its effect on ischemic strokes (EP-PARTICLES study). Sci. Rep. 2022, 12, 17150. [Google Scholar] [CrossRef]
  21. Kuźma, Ł.; Dąbrowski, E.J.; Kurasz, A.; Bachórzewska-Gajewska, H.; Dobrzycki, S. The 10-Year Study of the Impact of Particulate Matters on Mortality in Two Transit Cities in North-Eastern Poland (PL-PARTICLES). J. Clin. Med. 2020, 9, 3445. [Google Scholar] [CrossRef]
  22. Nemmar, A.; Holme, J.A.; Rosas, I.; Schwarze, P.E.; Alfaro-Moreno, E. Recent advances in particulate matter and nanoparticle toxicology: A review of the in vivo and in vitro studies. Biomed. Res. Int. 2013, 2013, 279371. [Google Scholar] [CrossRef]
  23. Chin, M.T. Basic mechanisms for adverse cardiovascular events associated with air pollution. Heart 2015, 101, 253–256. [Google Scholar] [CrossRef]
  24. Ostro, B.; Malig, B.; Broadwin, R.; Basu, R.; Gold, E.B.; Bromberger, J.T.; Derby, C.; Feinstein, S.; Greendale, G.A.; Jackson, E.A.; et al. Chronic PM2.5 exposure and inflammation: Determining sensitive subgroups in mid-life women. Environ. Res. 2014, 132, 168–175. [Google Scholar] [CrossRef]
  25. Rückerl, R.; Hampel, R.; Breitner, S.; Cyrys, J.; Kraus, U.; Carter, J.; Dailey, L.; Devlin, R.B.; Diaz-Sanchez, D.; Koenig, W.; et al. Associations between ambient air pollution and blood markers of inflammation and coagulation/fibrinolysis in susceptible populations. Environ. Int. 2014, 70, 32–49. [Google Scholar] [CrossRef] [PubMed]
  26. Sørensen, M.; Daneshvar, B.; Hansen, M.; Dragsted, L.O.; Hertel, O.; Knudsen, L.; Loft, S. Personal PM2.5 exposure and markers of oxidative stress in blood. Environ. Health Perspect. 2003, 111, 161–166. [Google Scholar] [CrossRef] [PubMed]
  27. Miller, M.R.; Raftis, J.B.; Langrish, J.P.; McLean, S.G.; Samutrtai, P.; Connell, S.P.; Wilson, S.; Vesey, A.T.; Fokkens, P.H.B.; Boere, A.J.F.; et al. Inhaled nanoparticles accumulate at sites of vascular disease. ACS Nano 2017, 11, 4542–4552. [Google Scholar] [CrossRef]
  28. Krishnan, R.M.; Adar, S.D.; Szpiro, A.A.; Jorgensen, N.W.; Van Hee, V.C.; Barr, R.G.; O’Neill, M.S.; Herrington, D.M.; Polak, J.F.; Kaufman, J.D. Vascular responses to long- and short-term exposure to fine particulate matter: MESA Air (Multi-Ethnic Study of Atherosclerosis and Air Pollution). J. Am. Coll. Cardiol. 2012, 60, 2158–2166. [Google Scholar] [CrossRef]
  29. Wilker, E.H.; Ljungman, P.L.; Rice, M.B.; Kloog, I.; Schwartz, J.; Gold, D.R.; Koutrakis, P.; Vita, J.A.; Mitchell, G.F.; Vasan, R.S.; et al. Relation of long-term exposure to air pollution to brachial artery flow-mediated dilation and reactive hyperemia. Am. J. Cardiol. 2014, 113, 2057–2063. [Google Scholar] [CrossRef]
  30. Wei, Y.; Zhang, J.J.; Li, Z.; Gow, A.; Chung, K.F.; Hu, M.; Sun, Z.; Zeng, L.; Zhu, T.; Jia, G.; et al. Chronic exposure to air pollution particles increases the risk of obesity and metabolic syndrome: Findings from a natural experiment in Beijing. FASEB J. 2016, 30, 2115–2122. [Google Scholar] [CrossRef]
  31. Chen, Z.; Salam, M.T.; Toledo-Corral, C.; Watanabe, R.M.; Xiang, A.H.; Buchanan, T.A.; Habre, R.; Bastain, T.M.; Lurmann, F.; Wilson, J.P.; et al. Ambient air pollutants have adverse effects on insulin and glucose homeostasis in Mexican Americans. Diabetes Care 2016, 39, 547–554. [Google Scholar] [CrossRef]
  32. Wolf, K.; Popp, A.; Schneider, A.; Breitner, S.; Hampel, R.; Rathmann, W.; Herder, C.; Roden, M.; Koenig, W.; Meisinger, C.; et al. Association between long-term exposure to air pollution and biomarkers related to insulin resistance, subclinical inflammation, and adipokines. Diabetes 2016, 65, 3314–3326. [Google Scholar] [CrossRef]
  33. Wang, L.; He, Y.; Han, C.; Zhu, P.; Zhou, Y.; Tang, R.; He, W. Global burden of chronic kidney disease and risk factors, 1990–2021: An update from the global burden of disease study 2021. Front. Public Health 2025, 13, 1542329. [Google Scholar] [CrossRef]
  34. United States Renal Data System. 2024 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, USA, 2024. [Google Scholar]
  35. Global Burden of Disease Study 2017. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020, 395, 709–733. [Google Scholar] [CrossRef]
  36. Sarnak, M.J.; Levey, A.S.; Schoolwerth, A.C.; Coresh, J.; Culleton, B.F.; Hamm, L.L.; Hostetter, T.H.; Hsu, C.Y.; Kusek, J.W.; Lash, J.P. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108, 2154–2169. [Google Scholar] [CrossRef]
  37. Wathanavasin, W.; Banjongjit, A.; Phannajit, J.; Eiam-Ong, S.; Susantitaphong, P. Association of fine particulate matter (PM2.5) exposure and chronic kidney disease outcomes: A systematic review and meta-analysis. Sci. Rep. 2024, 14, 1048. [Google Scholar] [CrossRef] [PubMed]
  38. Rasking, L.; Koshy, P.; Bongaerts, E.; Bové, H.; Ameloot, M.; Plusquin, M.; De Vusser, K.; Nawrot, T.S. Ambient black carbon reaches the kidneys. Environ. Int. 2023, 177, 107997. [Google Scholar] [CrossRef] [PubMed]
  39. Bowe, B.; Artimovich, E.; Xie, Y.; Yan, Y.; Cai, M.; Al-Aly, Z. The global and national burden of chronic kidney disease attributable to ambient fine particulate matter air pollution: A modelling study. BMJ Glob. Health 2020, 5, e002063. [Google Scholar] [CrossRef] [PubMed]
  40. Nemmar, A.; Al-Salam, S.; Zia, S.; Yasin, J.; Al Husseni, I.; Ali, B.H. Diesel exhaust particles in the lung aggravate experimental acute renal failure. Toxicol. Sci. 2010, 113, 267–277. [Google Scholar] [CrossRef]
  41. Nemmar, A.; Beegam, S.; Yuvaraju, P.; Yasin, J.; Fahim, M.A.; Kazzam, E.E.; Alhaddabi, I.; Ali, B.H. Potentiation of cisplatin-induced nephrotoxicity by repeated exposure to diesel exhaust particles: An experimental study in rats. Exp. Biol. Med. 2014, 239, 1036–1044. [Google Scholar] [CrossRef]
  42. Nemmar, A.; Karaca, T.; Beegam, S.; Yuvaraju, P.; Yasin, J.; Hamadi, N.K.; Ali, B.H. Prolonged Pulmonary Exposure to Diesel Exhaust Particles Exacerbates Renal Oxidative Stress, Inflammation and DNA Damage in Mice with Adenine-Induced Chronic Renal Failure. Cell Physiol. Biochem. 2016, 38, 1703–1713. [Google Scholar] [CrossRef]
  43. Al Suleimani, Y.M.; Al Mahruqi, A.S.; Al Za’abi, M.; Shalaby, A.; Ashique, M.; Nemmar, A.; Ali, B.H. Effect of diesel exhaust particles on renal vascular responses in rats with chronic kidney disease. Environ. Toxicol. 2017, 32, 541–549. [Google Scholar] [CrossRef]
  44. Waly, M.I.; Ali, B.H.; Nemmar, A. Acute effects of diesel exhaust particles and cisplatin on oxidative stress in cultured human kidney (HEK 293) cells, and the influence of curcumin thereon. Toxicol. Vitr. 2013, 27, 2299–2304. [Google Scholar] [CrossRef]
  45. Rasking, L.; Vanbrabant, K.; Sun, P.; Vangeneugden, M.; Strauch, M.; Schins, R.P.F.; Cassee, F.R.; Bové, H.; De Vusser, K.; Nawrot, T.S.; et al. Kidney morphological changes associated with early-life carbonaceous ultrafine particle exposure: A pathomics approach. Environ. Res. 2025, 285 Pt 3, 122458. [Google Scholar] [CrossRef]
  46. Bowe, B.; Xie, Y.; Li, T.; Yan, Y.; Xian, H.; Al-Aly, Z. Particulate matter air P. Association of fine particulate matterdisease and progression to end-stage renal disease. J. Am. Soc. Nephrol. 2018, 29, 218–230. [Google Scholar] [CrossRef]
  47. Bowe, B.; Xie, Y.; Li, T.; Yan, Y.; Xian, H.; Al-Aly, Z. Associations of ambient coarse particulate matter, nitrogen dioxide, and carbon monoxide with the risk of kidney disease: A cohort study. Lancet Planet. Health 2017, 1, e267–e276. [Google Scholar] [CrossRef]
  48. Mehta, A.J.; Zanobetti, A.; Bind, M.A.; Kloog, I.; Koutrakis, P.; Sparrow, D.; Vokonas, P.S.; Schwartz, J.D. Long-Term Exposure to Ambient Fine Particulate Matter and Renal Function in Older Men: The Veterans Administration Normative Aging Study. Environ. Health Perspect. 2016, 124, 1353–1360. [Google Scholar] [CrossRef]
  49. Lee, W.; Wu, X.; Heo, S.; Fong, K.C.; Son, J.Y.; Sabath, M.B.; Braun, D.; Park, J.Y.; Kim, Y.C.; Lee, J.P.; et al. Associations between long term air pollution exposure and first hospital admission for kidney and total urinary system diseases in the US Medicare population: Nationwide longitudinal cohort study. BMJ Med. 2022, 1, e000009. [Google Scholar] [CrossRef] [PubMed]
  50. Ma, Y.; Zang, E.; Liu, Y.; Wei, J.; Lu, Y.; Krumholz, H.M.; Bell, M.L.; Chen, K. Long-term exposure to wildland fire smoke PM2.5 and mortality in the contiguous United States. medRxiv 2024. Erratum in Proc. Natl. Acad. Sci. USA 2024, 121, e2403960121. https://doi.org/10.1073/pnas.2403960121. [Google Scholar] [CrossRef]
  51. Do, K.; Zhang, Y. Assessing health risks and socioeconomic disparities associated with ambient air pollution and point sources across the United States. Environ. Pollut. 2025, 375, 126311. [Google Scholar] [CrossRef] [PubMed]
  52. Dillon, D.; Ward-Caviness, C.; Kshirsagar, A.V.; Moyer, J.; Schwartz, J.; Di, Q.; Weaver, A. Associations between long-term exposure to air pollution and kidney function utilizing electronic healthcare records: A cross-sectional study. Environ. Health 2024, 23, 43. [Google Scholar] [CrossRef]
  53. Adgate, J.L.; Erlandson, G.; Butler-Dawson, J.; Calvimontes-Barrientos, L.; Amezquita, L.; Seidel, J.; Barnoya, J.; Castro, C.; Coyoy, M.; Pérez, M.; et al. Airborne particulate matter exposure in male sugarcane workers at risk for chronic kidney disease in Guatemala. Ann. Work Expo. Health 2025, 69, 377–388. [Google Scholar] [CrossRef]
  54. Yang, Y.R.; Chen, Y.M.; Chen, S.Y.; Chan, C.C. Associations between long-term particulate matter exposure and adult renal function in the Taipei metropolis. Environ. Health Perspect. 2017, 125, 602–607. [Google Scholar] [CrossRef]
  55. Chen, Y.; Zhou, H.; Wang, S.; Dong, L.; Tang, Y.; Qin, W. Particulate matter exposure and end-stage renal disease risk in IgA nephropathy. Front. Med. 2025, 1–10. [Google Scholar] [CrossRef]
  56. Wu, J.L.; Chang, Y.T.; Lee, P.C.; Cheng, Y.Y.; Yu, T.; Wong, P.Y.; Da Wu, C.; Chen, P.S.; Li, C.Y. Association between exposure to air pollution and kidney function decline. Nephrol. Dial. Transplant. 2025, gfaf143. [Google Scholar] [CrossRef]
  57. Li, Y.L.; Chang, P.Y.; Chuang, T.W.; Hsieh, Y.C.; Wang, B.S.; Chen, S.Y.; Chiou, H.Y. Association of long-term ozone exposure with the incidence and progression of hypertension, diabetes, and chronic kidney disease: A national retrospective cohort study. Sci. Total Environ. 2025, 975, 179209. [Google Scholar] [CrossRef]
  58. Dai, Y.; Yin, J.; Li, S.; Li, J.; Han, X.; Deji, Q.; Pengcuo, C.; Liu, L.; Yu, Z.; Chen, L.; et al. Long-term exposure to fine particulate matter constituents in relation to chronic kidney disease: Evidence from a large population-based study in China. Environ. Geochem. Health 2024, 46, 174. [Google Scholar] [CrossRef] [PubMed]
  59. Huang, Y.-S.; Lo, L.-W.; Tsai, T.-Y.; Leu, H.-B.; Chen, S.-A. Short-term effects of ambient air pollution exposure on hospital emergency room visits for atrial fibrillation: A nationwide cohort study. IJC Hear. Vasc. 2025, 61, 101805. [Google Scholar] [CrossRef] [PubMed]
  60. Shang, Z.; Gao, Y.M.; Deng, Z.L.; Wang, Y. Long-term exposure to ambient air pollutants and increased risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease: A retrospective cohort study in Beijing, China. Environ. Sci. Pollut. Res. Int. 2024, 31, 5429–5443. [Google Scholar] [CrossRef]
  61. Liu, X.; Zhao, X.; Ye, L.; Hu, C.; Xie, Z.; Ma, J.; Wang, X.; Liang, W. The TyG Index Mediates Air-Pollution-Associated Chronic Kidney Disease Incidence in HIV/AIDS Patients: A 20-Year Cohort Study. Toxics 2025, 13, 669. [Google Scholar] [CrossRef]
  62. Peng, S.; Chen, B.; Li, Z.; Sun, J.; Liu, F.; Yin, X.; Zhou, Y.; Shen, H.; Xiang, H. Ambient ozone pollution impairs glucose homeostasis and contributes to renal function decline: Population-based evidence. Ecotoxicol. Environ. Saf. 2024, 269, 115803. [Google Scholar] [CrossRef]
  63. Li, Z.H.; Song, W.Q.; Qiu, C.S.; Li, H.M.; Tang, X.L.; Shen, D.; Zhang, P.D.; Zhang, X.R.; Ren, J.J.; Gao, J.; et al. Long-term air pollution exposure, habitual physical activity, and incident chronic kidney disease. Ecotoxicol. Environ. Saf. 2023, 265, 115492. [Google Scholar] [CrossRef]
  64. Wen, F.; Xie, Y.; Li, B.; Li, P.; Qi, H.; Zhang, F.; Sun, Y.; Zhang, L. Combined effects of ambient air pollution and PM2.5 components on renal function and the potential mediation effects of metabolic risk factors in China. Ecotoxicol. Environ. Saf. 2023, 259, 115039. [Google Scholar] [CrossRef]
  65. Zhang, X.; Tao, J.; Lei, F.; Sun, T.; Lin, L.; Huang, X.; Zhang, P.; Ji, Y.X.; Cai, J.; Zhang, X.J.; et al. Association of the components of ambient fine particulate matter (PM2.5) and chronic kidney disease prevalence in China. J. Environ. Manag. 2023, 339, 117885. [Google Scholar] [CrossRef] [PubMed]
  66. Wu, G.; Cai, M.; Wang, C.; Zou, H.; Wang, X.; Hua, J.; Lin, H. Ambient air pollution and incidence, progression to multimorbidity and death of hypertension, diabetes, and chronic kidney disease: A national prospective cohort. Sci. Total. Environ. 2023, 881, 163406. [Google Scholar] [CrossRef] [PubMed]
  67. Li, R.; Wang, K.; Li, M.; Liu, H.; You, Y.; Liu, D.; Guo, X.; Chen, J.; Wu, S. Association between ambient air pollution and renal function indicators: A comprehensive systematic review and meta-analysis. Environ. Res. 2025, 286, 122841. [Google Scholar] [CrossRef] [PubMed]
  68. Tang, W.Z.; Xu, W.Z.; Liu, T.H.; Cai, Q.Y.; Fei-Han Jia, Y.T.; Deng, B.Y.; Xiang, Z.Y.; Deng, Y.; Guo, P.; Ding, J. The impact of household air pollution from solid fuel use on rapid decline in kidney function and chronic kidney disease: A nationwide longitudinal cohort study. J. Nutr. Health Aging 2025, 29, 100641. [Google Scholar] [CrossRef]
  69. Leonetti, A.; Peansukwech, U.; Charnnarong, J.; Cha’on, U.; Suttiprapa, S.; Anutrakulchai, S. Effects of particulate matter (PM2.5) concentration and components on mortality in chronic kidney disease patients: A nationwide spatial-temporal analysis. Sci. Rep. 2024, 14, 16810. [Google Scholar] [CrossRef]
  70. Yi, J.; Kim, S.H.; Lee, H.; Chin, H.J.; Park, J.Y.; Jung, J.; Song, J.; Kwak, N.; Ryu, J.; Kim, S. Air quality and kidney health: Assessing the effects of PM10, PM2.5, CO, and NO2 on renal function in primary glomerulonephritis. Ecotoxicol. Environ. Saf. 2024, 281, 116593. [Google Scholar] [CrossRef]
  71. Kwon, S.; Sim, H.; Ko, A.; Lee, W.; Kim, H.; Han, S.H.; Hwang, H.S.; Kim, D.K.; Lim, C.S.; Kim, Y.S.; et al. Long-term impact of PM2.5 exposure on diabetic kidney disease patients considering time-dependent medication adjustment. Clin. Kidney J. 2025, 18, sfaf216. [Google Scholar] [CrossRef]
  72. Baek, S.U.; Yoon, J.H. Long-term joint exposure of outdoor air pollutants and impaired kidney function in Korean adults: A mixture analysis based on a nationwide sample (2007–2019). Environ. Toxicol. Pharmacol. 2025, 116, 104712. [Google Scholar] [CrossRef]
  73. Choi, J.; Lim, H.; Kwon, H.J.; Ha, M.; Kim, S.; Choi, K.H. Ambient fine particulate matter and mortality risk among people with disability in Korea based on the National Health Insurance database: A retrospective cohort study. BMC Public Health 2025, 25, 1654. [Google Scholar] [CrossRef]
  74. Nagai, K.; Araki, S.; Sairenchi, T.; Ueda, K.; Yamagishi, K.; Shima, M.; Yamamoto, K.; Iso, H.; Irie, F. Particulate Matter and Incident Chronic Kidney Disease in Japan: The Ibaraki Prefectural Health Study (IPHS). JMA J. 2024, 7, 334–341. [Google Scholar] [CrossRef]
  75. Kuźma, Ł.; Małyszko, J.; Bachórzewska-Gajewska, H.; Kralisz, P.; Dobrzycki, S. Exposure to air pollution and renal function. Sci. Rep. 2021, 11, 11419. [Google Scholar] [CrossRef]
  76. Hamroun, A.; Génin, M.; Glowacki, F.; Sautenet, B.; Leffondré, K.; De Courrèges, A.; Dauchet, L.; Gauthier, V.; Bayer, F.; Lassalle, M.; et al. Multiple air pollutant exposure is associated with higher risk of all-cause mortality in dialysis patients: A French registry-based nationwide study. Front. Public Health 2024, 12, 1390999. [Google Scholar] [CrossRef] [PubMed]
  77. Cesaroni, G.; Jaensch, A.; Renzi, M.; Marino, C.; Ferraro, P.M.; Kerschbaum, J.; Haller, P.; Brozek, W.; Michelozzi, P.; Stafoggia, M.; et al. Association of air pollution with incidence of end-stage kidney disease in two large European cohorts. Sci. Total. Environ. 2024, 948, 174796. [Google Scholar] [CrossRef] [PubMed]
  78. Kadelbach, P.; Weinmayr, G.; Chen, J.; Jaensch, A.; Rodopoulou, S.; Strak, M.; de Hoogh, K.; Andersen, Z.J.; Bellander, T.; Brandt, J.; et al. Long-term exposure to air pollution and chronic kidney disease-associated mortality-Results from the pooled cohort of the European multicentre ELAPSE-study. Environ. Res. 2024, 252 Pt 3, 118942. [Google Scholar] [CrossRef] [PubMed]
  79. He, P.; Chen, R.; Zhou, L.; Li, Y.; Su, L.; Dong, J.; Zha, Y.; Lin, Y.; Nie, S.; Hou, F.F.; et al. Higher ambient nitrogen dioxide is associated with an elevated risk of hospital-acquired acute kidney injury. Clin. Kidney J. 2021, 15, 95–100. [Google Scholar] [CrossRef]
  80. Fang, J.; Tang, S.; Zhou, J.; Zhou, J.; Cui, L.; Kong, F.; Gao, Y.; Shen, Y.; Deng, F.; Zhang, Y.; et al. Associations between personal PM2.5 elemental constituents and decline of kidney function in older individuals: The China BAPE study. Environ. Sci. Technol. 2020, 54, 13167–13174. [Google Scholar] [CrossRef]
  81. Bi, J.; Barry, V.; Weil, E.J.; Chang, H.H.; Ebelt, S. Short-term exposure to fine particulate air pollution and emergency department visits for kidney diseases in the Atlanta metropolitan area. Environ. Epidemiol. 2021, 5, e164. [Google Scholar] [CrossRef]
  82. Gao, X.; Koutrakis, P.; Coull, B.; Lin, X.; Vokonas, P.; Schwartz, J.; Baccarelli, A.A. Short-term exposure to PM2.5 components and renal health: Findings from the Veterans Affairs Normative Aging Study. J. Hazard. Mater. 2021, 420, 126557. [Google Scholar] [CrossRef]
  83. Lee, W.; Prifti, K.; Kim, H.; Kim, E.; Yang, J.; Min, J.; Park, J.Y.; Kim, Y.C.; Lee, J.P.; Bell, M.L. Short-term exposure to air pollution and attributable risk of kidney diseases: A nationwide time-series study. Epidemiology 2022, 33, 17–24. [Google Scholar] [CrossRef]
  84. Wu, J.; Ye, Q.; Fang, L.; Deng, L.; Liao, T.; Liu, B.; Lv, X.; Zhang, J.; Tao, J.; Ye, D. Short-term association of NO2 with hospital visits for chronic kidney disease and effect modification by temperature in Hefei, China: A time series study. Ecotoxicol. Environ. Saf. 2022, 237, 113505. [Google Scholar] [CrossRef]
  85. Cai, M.; Wei, J.; Zhang, S.; Liu, W.; Wang, L.; Qian, Z.; Lin, H.; Liu, E.; McMillin, S.E.; Cao, Y.; et al. Short-term air pollution exposure associated with death from kidney diseases: A nationwide time-stratified case-crossover study in China from 2015 to 2019. BMC Med. 2023, 21, 32. [Google Scholar] [CrossRef]
  86. Chu, L.; Chen, K.; Di, Q.; Crowley, S.; Dubrow, R. Associations between short-term exposure to PM2.5, NO2 and O3 pollution and kidney-related conditions and the role of temperature-adjustment specification: A case-crossover study in New York state. Environ. Pollut. 2023, 328, 121629. [Google Scholar] [CrossRef] [PubMed]
  87. Chen, H.; Duan, Q.; Zhu, H.; Wan, S.; Zhao, X.; Ye, D.; Fang, X. Short-term association of CO and NO2 with hospital visits for glomerulonephritis in Hefei, China: A time series study. Front. Public Health 2023, 11, 1239378. [Google Scholar] [CrossRef] [PubMed]
  88. Ma, H.; Liang, W.; Han, A.; Zhang, Q.; Gong, S.; Bai, Y.; Gao, D.; Xiang, H.; Wang, X. Ambient particulate matter and renal function decline in people with HIV/AIDS. AIDS 2024, 38, 713–721. [Google Scholar] [CrossRef] [PubMed]
  89. Kim, H.J.; Min, J.Y.; Seo, Y.S.; Min, K.B. Association between exposure to ambient air pollution and renal function in Korean adults. Ann. Occup. Environ. Med. 2018, 30, 14. [Google Scholar] [CrossRef]
  90. Chen, S.Y.; Chu, D.C.; Lee, J.H.; Yang, Y.R.; Chan, C.C. Traffic-related air pollution associated with chronic kidney disease among elderly residents in Taipei City. Environ. Pollut. 2018, 234, 838–845. [Google Scholar] [CrossRef]
  91. Bragg-Gresham, J.; Morgenstern, H.; McClellan, W.; Saydah, S.; Pavkov, M.; Williams, D.; Powe, N.; Tuot, D.; Hsu, R.; Saran, R.; et al. County-level air quality and the prevalence of diagnosed chronic kidney disease in the US Medicare population. PLoS ONE 2018, 13, e0200612. [Google Scholar] [CrossRef]
  92. Chan, T.C.; Zhang, Z.; Lin, B.C.; Lin, C.; Deng, H.B.; Chuang, Y.C.; Chan, J.W.M.; Jiang, W.K.; Tam, T.; Chang, L.Y.; et al. Long-Term Exposure to Ambient Fine Particulate Matter and Chronic Kidney Disease: A Cohort Study. Environ. Health Perspect. 2018, 126, 107002. [Google Scholar] [CrossRef]
  93. Blum, M.F.; Surapaneni, A.; Stewart, J.D.; Liao, D.; Yanosky, J.D.; Whitsel, E.A.; Power, M.C.; Grams, M.E. Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD. Clin. J. Am. Soc. Nephrol. 2020, 15, 311–319. [Google Scholar] [CrossRef]
  94. Wang, W.; Wu, C.; Mu, Z.; Gu, Y.; Zheng, Y.; Ren, L.; Hu, Y.; Liang, A.; Peng, L.; Zhang, L.; et al. Effect of ambient air pollution exposure on renal dysfunction among hospitalized patients in Shanghai, China. Public Health 2020, 181, 196–201. [Google Scholar] [CrossRef]
  95. Ran, J.; Yang, A.; Sun, S.; Han, L.; Li, J.; Guo, F.; Zhao, S.; Yang, Y.; Mason, T.G.; Chan, K.P.; et al. Long-Term Exposure to Ambient Fine Particulate Matter and Mortality from Renal Failure: A Retrospective Cohort Study in Hong Kong, China. Am. J. Epidemiol. 2020, 189, 602–612. [Google Scholar] [CrossRef]
  96. Lin, S.Y.; Ju, S.W.; Lin, C.L.; Hsu, W.H.; Lin, C.C.; Ting, I.W.; Kao, C.H. Air pollutants and subsequent risk of chronic kidney disease and end-stage renal disease: A population-based cohort study. Environ. Pollut. 2020, 261, 114154. [Google Scholar] [CrossRef]
  97. Lin, Y.T.; Lo, Y.C.; Chiang, H.Y.; Jung, C.R.; Wang, C.M.; Chan, T.C.; Kuo, C.C.; Hwang, B.F. Particulate Air Pollution and Progression to Kidney Failure with Replacement Therapy: An Advanced CKD Registry-Based Cohort Study in Taiwan. Am. J. Kidney Dis. 2020, 76, 645–657.e1. [Google Scholar] [CrossRef]
  98. Bo, Y.; Brook, J.R.; Lin, C.; Chang, L.Y.; Guo, C.; Zeng, Y.; Yu, Z.; Tam, T.; Lau, A.K.H.; Lao, X.Q. Reduced Ambient PM2.5 Was Associated with a Decreased Risk of Chronic Kidney Disease: A Longitudinal Cohort Study. Environ. Sci. Technol. 2021, 55, 6876–6883. [Google Scholar] [CrossRef]
  99. Feng, Y.M.; Thijs, L.; Zhang, Z.Y.; Bijnens, E.M.; Yang, W.Y.; Wei, F.F.; Janssen, B.G.; Nawrot, T.S.; Staessen, J.A. Glomerular function in relation to fine airborne particulate matter in a representative population sample. Sci. Rep. 2021, 11, 14646. [Google Scholar] [CrossRef]
  100. Li, S.; Meng, Q.; Laba, C.; Guan, H.; Wang, Z.; Pan, Y.; Wei, J.; Xu, H.; Zeng, C.; Wang, X.; et al. Associations between long-term exposure to ambient air pollution and renal function in Southwest China: The China Multi-Ethnic Cohort (CMEC) study. Ecotoxicol. Environ. Saf. 2022, 242, 113851. [Google Scholar] [CrossRef] [PubMed]
  101. Li, G.; Huang, J.; Wang, J.; Zhao, M.; Liu, Y.; Guo, X.; Wu, S.; Zhang, L. Long-Term Exposure to Ambient PM2.5 and Increased Risk of CKD Prevalence in China. J. Am. Soc. Nephrol. 2021, 32, 448–458, Erratum in J. Am. Soc. Nephrol. 2021, 32, 2101. https://doi.org/10.1681/ASN.2021050692. [Google Scholar] [CrossRef] [PubMed]
  102. Jung, J.; Park, J.Y.; Kim, Y.C.; Lee, H.; Kim, E.; Kim, Y.S.; Lee, J.P.; Kim, H. Effects of air pollution on mortality of patients with chronic kidney disease: A large observational cohort study. Sci. Total Environ. 2021, 786, 147471. [Google Scholar] [CrossRef] [PubMed]
  103. Paoin, K.; Ueda, K.; Vathesatogkit, P.; Ingviya, T.; Buya, S.; Dejchanchaiwong, R.; Phosri, A.; Seposo, X.T.; Kitiyakara, C.; Thongmung, N.; et al. Long-term air pollution exposure and decreased kidney function: A longitudinal cohort study in Bangkok Metropolitan Region, Thailand from 2002 to 2012. Chemosphere 2022, 287 Pt 1, 132117. [Google Scholar] [CrossRef]
  104. Xu, Y.; Andersson, E.M.; Krage Carlsen, H.; Molnár, P.; Gustafsson, S.; Johannesson, S.; Oudin, A.; Engström, G.; Christensson, A.; Stockfelt, L. Associations between long-term exposure to low-level air pollution and risk of chronic kidney disease-findings from the Malmö Diet and Cancer cohort. Environ. Int. 2022, 160, 107085. [Google Scholar] [CrossRef]
  105. Wu, Y.H.; Wu, C.D.; Chung, M.C.; Chen, C.H.; Wu, L.Y.; Chung, C.J.; Hsu, H.T. Long-Term Exposure to Fine Particulate Matter and the Deterioration of Estimated Glomerular Filtration Rate: A Cohort Study in Patients with Pre-End-Stage Renal Disease. Front. Public Health 2022, 10, 858655. [Google Scholar] [CrossRef]
  106. Lin, H.C.; Hung, P.H.; Hsieh, Y.Y.; Lai, T.J.; Hsu, H.T.; Chung, M.C.; Chung, C.J. Long-term exposure to air pollutants and increased risk of chronic kidney disease in a community-based population using a fuzzy logic inference model. Clin Kidney J. 2022, 15, 1872–1880. [Google Scholar] [CrossRef] [PubMed]
  107. Ghazi, L.; Drawz, P.E.; Berman, J.D. The association between fine particulate matter (PM2.5) and chronic kidney disease using electronic health record data in urban Minnesota. J. Expo. Sci. Environ. Epidemiol. 2022, 32, 583–589. [Google Scholar] [CrossRef] [PubMed]
  108. Wu, C.Y.; Hsu, C.T.; Chung, M.C.; Chen, C.H.; Wu, M.J. Air Pollution Alleviation During COVID-19 Pandemic is Associated with Renal Function Decline in Stage 5 CKD Patients. J. Multidiscip. Health 2022, 15, 1901–1908. [Google Scholar] [CrossRef] [PubMed]
  109. Oh, J.; Ye, S.; Kang, D.H.; Ha, E. Association between exposure to fine particulate matter and kidney function: Results from the Korea National Health and Nutrition Examination Survey. Environ. Res. 2022, 212 Pt A, 113080. [Google Scholar] [CrossRef] [PubMed]
  110. Huh, H.; Kim, E.; Yoon, U.A.; Choi, M.J.; Lee, H.; Kwon, S.; Kim, C.T.; Kim, D.K.; Kim, Y.S.; Lim, C.S.; et al. Ambient carbon monoxide correlates with mortality risk of hemodialysis patients: Comparing results of control selection in the case-crossover designs. Kidney Res. Clin. Pract. 2022, 41, 601–610. [Google Scholar] [CrossRef]
  111. Liu, L.; Tian, X.; Zhao, Y.; Zhao, Z.; Luo, L.; Luo, H.; Han, Z.; Kang, X.; Wang, X.; Liu, X.; et al. Long-term exposure to PM2.5 and PM10 and chronic kidney disease: The Beijing Health Management Cohort, from 2013 to 2018. Environ. Sci. Pollut. Res. Int. 2023, 30, 17817–17827. [Google Scholar] [CrossRef]
  112. Liu, H.; Shao, X.; Jiang, X.; Liu, X.; Bai, P.; Lin, Y.; Chen, J.; Hou, F.; Cui, Z.; Zhang, Y.; et al. Joint exposure to outdoor ambient air pollutants and incident chronic kidney disease: A prospective cohort study with 90,032 older adults. Front. Public Health 2022, 10, 992353. [Google Scholar] [CrossRef]
  113. Duan, J.W.; Li, Y.L.; Li, S.X.; Yang, Y.P.; Li, F.; Li, Y.; Wang, J.; Deng, P.Z.; Wu, J.J.; Wang, W.; et al. Association of Long-term Ambient Fine Particulate Matter (PM2.5) and Incident CKD: A Prospective Cohort Study in China. Am. J. Kidney Dis. 2022, 80, 638–647.e1. [Google Scholar] [CrossRef]
  114. Yang, C.; Wang, W.; Wang, Y.; Liang, Z.; Zhang, F.; Chen, R.; Liang, C.; Wang, F.; Li, P.; Ma, L.; et al. Ambient ozone pollution and prevalence of chronic kidney disease: A nationwide study based on the China National survey of chronic kidney disease. Chemosphere 2022, 306, 135603. [Google Scholar] [CrossRef]
  115. Guo, C.; Chang, L.Y.; Wei, X.; Lin, C.; Zeng, Y.; Yu, Z.; Tam, T.; Lau, A.K.H.; Huang, B.; Lao, X.Q. Multi-pollutant air pollution and renal health in Asian children and adolescents: An 18-year longitudinal study. Environ. Res. 2022, 214 Pt 4, 114144. [Google Scholar] [CrossRef]
  116. Luo, C.; Ouyang, Y.; Shi, S.; Li, G.; Zhao, Z.; Luo, H.; Xu, F.; Shao, L.; Chen, Z.; Yu, S.; et al. Particulate matter of air pollution may increase risk of kidney failure in IgA nephropathy. Kidney Int. 2022, 102, 1382–1391. [Google Scholar] [CrossRef]
  117. Chang, P.Y.; Li, Y.L.; Chuang, T.W.; Chen, S.Y.; Lin, L.Y.; Lin, Y.F.; Chiou, H.Y. Exposure to ambient air pollutants with kidney function decline in chronic kidney disease patients. Environ. Res. 2022, 215 Pt 2, 114289. [Google Scholar] [CrossRef]
  118. Wang, J.; Li, D.; Sun, Y.; Tian, Y. Air pollutants, genetic factors, and risk of chronic kidney disease: Findings from the UK Biobank. Ecotoxicol. Environ. Saf. 2022, 247, 114219. [Google Scholar] [CrossRef]
  119. Hu, L.K.; Liu, Y.H.; Yang, K.; Chen, N.; Ma, L.L.; Yan, Y.X. Associations between long-term exposure to ambient fine particulate pollution with the decline of kidney function and hyperuricemia: A longitudinal cohort study. Environ. Sci. Pollut. Res. Int. 2023, 30, 40507–40518. [Google Scholar] [CrossRef] [PubMed]
  120. Chen, S.F.; Chien, Y.H.; Chen, P.C. The association between long-term ambient fine particulate exposure and the mortality among adult patients initiating dialysis: A retrospective population-based cohort study in Taiwan. Environ. Pollut. 2023, 316 Pt 2, 120606. [Google Scholar] [CrossRef] [PubMed]
  121. Su, W.Y.; Wu, D.W.; Tu, H.P.; Chen, S.C.; Hung, C.H.; Kuo, C.H. Association between ambient air pollutant interaction with kidney function in a large Taiwanese population study. Environ. Sci. Pollut. Res. Int. 2023, 30, 82341–82352. [Google Scholar] [CrossRef] [PubMed]
  122. Li, J.; Dai, L.; Deng, X.; Zhang, J.; Song, C.; Xu, J.; Wang, A.; Xiong, Z.; Shan, Y.; Huang, X. Association between long-term exposure to low level air pollutants and incident end-stage kidney disease in the UK Biobank: A prospective cohort. Chemosphere 2023, 338, 139470. [Google Scholar] [CrossRef]
  123. Zhang, Y.; Tang, C.; Liu, Y.; Jiang, H.; Lu, J.; Lu, Z.; Xu, L.; Zhang, S.; Zhou, L.; Ye, J.; et al. Long-term ozone exposure is negatively associated with estimated glomerular filtration rate in Chinese middle-aged and elderly adults. Chemosphere 2023, 341, 140040. [Google Scholar] [CrossRef]
  124. Zhang, F.; Yang, C.; Wang, F.; Liu, Y.; Guo, C.G.; Li, P.; Zhang, L. Air pollution and the risk of incident chronic kidney disease in patients with diabetes: An exposure-response analysis. Ecotoxicol. Environ. Saf. 2024, 270, 115829. [Google Scholar] [CrossRef]
  125. Peng, S.; Yin, X.; Chen, G.; Sun, J.; Chen, B.; Zhou, Y.; Li, Z.; Liu, F.; Xiang, H. Long-term exposure to varying-sized particulate matters and kidney disease in middle-aged and elder adults: A 8-year nationwide cohort study in China. Sci. Total Environ. 2024, 911, 168621. [Google Scholar] [CrossRef] [PubMed]
  126. Yang, C.; Wang, W.; Wang, F.; Wang, Y.; Zhang, F.; Liang, Z.; Liang, C.; Wang, J.; Ma, L.; Li, P.; et al. Ambient PM2.5 components and prevalence of chronic kidney disease: A nationwide cross-sectional survey in China. Environ. Geochem. Health 2024, 46, 70. [Google Scholar] [CrossRef] [PubMed]
  127. Kim, E.; Huh, H.; Mo, Y.; Park, J.Y.; Jung, J.; Lee, H.; Kim, S.; Kim, D.K.; Kim, Y.S.; Lim, C.S.; et al. Long-term ozone exposure and mortality in patients with chronic kidney disease: A large cohort study. BMC Nephrol. 2024, 25, 74. [Google Scholar] [CrossRef] [PubMed]
  128. Hwang, S.Y.; Jeong, S.; Choi, S.; Kim, D.H.; Kim, S.R.; Lee, G.; Son, J.S.; Park, S.M. Association of Air Pollutants with Incident Chronic Kidney Disease in a Nationally Representative Cohort of Korean Adults. Int. J. Environ. Res. Public Health 2021, 18, 3775. [Google Scholar] [CrossRef]
  129. Chen, R.; Yang, C.; Guo, Y.; Chen, G.; Li, S.; Li, P.; Wang, J.; Meng, R.; Wang, H.-Y.; Peng, S.; et al. Association between ambient PM1 and the prevalence of chronic kidney disease in China: A nationwide study. J. Hazard. Mater. 2024, 468, 133827. [Google Scholar] [CrossRef]
  130. Zhao, Z.; Liu, L.; Tian, X.; Luo, L.; Luo, H.; Kang, X.; Wang, X.; Liu, X.; Guo, X.; Luo, Y. Association between exposure to PM_(2.5) and chronic kidney disease in a population with metabolic syndrome. J. Hyg. Res. 2024, 53, 427–434. [Google Scholar] [CrossRef]
  131. Kilbo Edlund, K.; Xu, Y.; Andersson, E.M.; Christensson, A.; Dehlin, M.; Forsblad-d’Elia, H.; Harari, F.; Ljunggren, S.; Molnár, P.; Oudin, A.; et al. Long-term ambient air pollution exposure and renal function and biomarkers of renal disease. Environ. Health 2024, 23, 67. [Google Scholar] [CrossRef]
  132. Chin, W.S.; Guo, Y.L.; Chang, Y.K.; Huang, L.F.; Hsu, C.C. Long-term exposure to NO2 and PM2.5 and the occurrence of chronic kidney disease among patients with type 2 diabetes in Taiwan. Ecotoxicol. Environ. Saf. 2024, 284, 116940. [Google Scholar] [CrossRef]
  133. Kellum, J.A.; Lameire, N.; Aspelin, P.; Barsoum, R.S.; Burdmann, E.A.; Goldstein, S.L.; Herzog, C.A.; Joannidis, M.; Kribben, A.; Levey, A.S.; et al. Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2012, 2, 1–138. [Google Scholar] [CrossRef]
  134. Lameire, N.H.; Levin, A.; Kellum, J.A.; Cheung, M.; Jadoul, M.; Winkelmayer, W.C.; Stevens, P.E.; Conference Participants. Harmonizing acute and chronic kidney disease definition and classification: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021, 100, 516–526. [Google Scholar] [CrossRef]
  135. Sanches, T.R.; Parra, A.C.; Sun, P.; Graner, M.P.; Itto, L.Y.U.; Butter, L.M.; Claessen, N.; Roelofs, J.J.; Florquin, S.; Veras, M.M.; et al. Air pollution aggravates renal ischaemia-reperfusion-induced acute kidney injury. J. Pathol. 2024, 263, 496–507. [Google Scholar] [CrossRef] [PubMed]
  136. Hou, T.; Jiang, Y.; Zhang, J.; Hu, R.; Li, S.; Fan, W.; Chen, R.; Zhang, L.; Li, R.; Qin, L.; et al. Kidney injury evoked by fine particulate matter: Risk factor, causation, mechanism and intervention study. Adv. Sci. 2024, 11, e2403222. [Google Scholar] [CrossRef] [PubMed]
  137. Lee, W.; Wu, X.; Heo, S.; Kim, J.M.; Fong, K.C.; Son, J.Y.; Sabath, M.B.; Trisovic, A.; Braun, D.; Park, J.Y.; et al. Air pollution and acute kidney injury in the U.S. Medicare population: A longitudinal cohort study. Environ. Health Perspect. 2023, 131, 47008. [Google Scholar] [CrossRef] [PubMed]
  138. Min, J.; Lee, W.; Kang, D.H.; Ahn, S.; Kim, A.; Kang, C.; Oh, J.; Jang, H.; Ho Jo, C.; Oh, J.; et al. Air pollution and acute kidney injury with comorbid disease: A nationwide case-crossover study in South Korea. Environ. Res. 2024, 260, 119608. [Google Scholar] [CrossRef]
  139. Min, J.; Kang, D.H.; Kang, C.; Bell, M.L.; Kim, H.; Yang, J.; Gasparrini, A.; Lavigne, E.; Hashizume, M.; Kim, Y.; et al. Fluctuating risk of acute kidney injury-related mortality for four weeks after exposure to air pollution: A multi-country time-series study in six countries. Environ Int. 2024, 183, 108367. [Google Scholar] [CrossRef]
  140. López-Bueno, J.; Díaz, J.; Padrón-Monedero, A.; Martín, M.N.; Linares, C. Short-term impact of extreme temperatures, relative humidity and air pollution on emergency hospital admissions due to kidney disease and kidney-related conditions in the Greater Madrid area (Spain). Sci. Total. Environ. 2023, 903, 166646. [Google Scholar] [CrossRef]
  141. Liu, M.; Gao, M.; Hu, D.; Hu, J.; Wu, J.; Chen, Z.; Chen, J. Prolonged exposure to air pollution and risk of acute kidney injury and related mortality: A prospective cohort study based on hospitalized AKI cases and general population controls from the UK Biobank. BMC Public Health 2024, 24, 2911. [Google Scholar] [CrossRef]
  142. Xiao, Y.; Liu, C.; Liu, Y.; Luo, H.; Zhu, Y.; Zhou, L.; Gao, Y.; Zhang, H.; Chen, R.; Xuan, J.; et al. Association between air pollution and hospitalization for acute exacerbation of kidney failure: A nationwide time-stratified case-crossover study in China. J. Hazard. Mater. 2025, 485, 136834. [Google Scholar] [CrossRef]
  143. Zhao, L.; Zhao, C.; Sun, W.; Zheng, H.; Gao, Y.; Wa, C.K.; Wang, Q.; Liu, Q.; Wang, Y.; Wang, Z. Long-term air pollution exposure and cardiovascular disease risk across cardiovascular-renal-metabolic stages: A nationwide study. BMC Public Health 2025, 25, 2179. [Google Scholar] [CrossRef]
  144. Shi, Y.; Qiu, J.; Xue, J.; Zhang, Y.; Su, M.; Zhou, Q.; Huang, S.; Liang, Z.; Wu, Y.; Liang, H.; et al. Divergent impacts of air pollution on cardiovascular-kidney-metabolic progression: Comparative evidence from Chinese vs. British cohorts. J. Hazard. Mater. 2025, 495, 139097. [Google Scholar] [CrossRef]
  145. Blankestijn, P.J.; Arici, M.; Bruchfeld, A.; Capasso, G.; Fliser, D.; Fouque, D.; Goumenos, D.; Ketteler, M.; Malyszko, J.; Massy, Z.; et al. ERA-EDTA invests in transformation to greener health care. Nephrol. Dial. Transplant. 2018, 33, 901–903. [Google Scholar] [CrossRef] [PubMed]
  146. Watts, N.; Amann, M.; Ayeb-Karlsson, S.; Belesova, K.; Bouley, T.; Boykoff, M.; Byass, P.; Cai, W.; Campbell-Lendrum, D.; Chambers, J.; et al. The Lancet Countdown on health and climate change: From 25 years of inaction to a global transformation for public health. Lancet 2018, 391, 581–630. [Google Scholar] [CrossRef] [PubMed]
  147. Vanholder, R.; Agar, J.; Braks, M.; Gallego, D.; Gerritsen, K.G.F.; Harber, M.; Noruisiene, E.; Pancirova, J.; Piccoli, G.B.; Stamatialis, D.; et al. The European Green Deal and nephrology: A call for action by the European Kidney Health Alliance. Nephrol. Dial. Transplant. 2023, 38, 1080–1088. [Google Scholar] [CrossRef] [PubMed]
  148. Štefanac, T.; Grgas, D.; Landeka Dragičević, T. Xenobiotics-Division and Methods of Detection: A Review. J. Xenobiot. 2021, 11, 130–141. [Google Scholar] [CrossRef]
  149. Olowu, W.A.; Niang, A.; Osafo, C.; Ashuntantang, G.; Arogundade, F.A.; Porter, J.; Naicker, S.; Luyckx, V.A. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: A systematic review. Lancet Glob. Health 2016, 4, e242–e250. [Google Scholar] [CrossRef]
  150. Romo-García, M.F.; Mendoza-Cano, O.; Murillo-Zamora, E.; Camacho-delaCruz, A.A.; Ríos-Silva, M.; Bricio-Barrios, J.A.; Cuevas-Arellano, H.B.; Rivas-Santiago, B.; Maeda-Gutiérrez, V.; Galván-Tejada, C.E.; et al. Glyphosate exposure increases early kidney injury biomarker KIM-1 in the pediatric population: A cross-sectional study. Sci. Total. Environ. 2025, 980, 179533. [Google Scholar] [CrossRef]
  151. Jayasumana, C.; Paranagama, P.; Agampodi, S.; Wijewardane, C.; Gunatilake, S.; Siribaddana, S. Drinking well water and occupational exposure to herbicides is associated with chronic kidney disease, in Padavi-Sripura, Sri Lanka. Environ. Health 2015, 14, 6. [Google Scholar] [CrossRef]
  152. Candiotto, L.Z.P.; Gaboardi, S.C.; Ferreira, M.O.; Teixeira, G.T.; Silva JCd Ferreira, I.N.; Tedesco, E.H.; Panis, C. Avaliação diagnóstica da presença de resíduos de agrotóxicos em amostras de urina de moradores de uma “vila rural” do município de Francisco Beltrão/PR. Ambient. Rev. Geogr. Ecol. Política 2022, 4, 227–261. [Google Scholar] [CrossRef]
  153. de Morais Valentim, J.M.B.; Coradi, C.; Viana, N.P.; Fagundes, T.R.; Micheletti, P.L.; Gaboardi, S.C.; Fadel, B.; Pizzatti, L.; Candiotto, L.Z.P.; Panis, C. Glyphosate as a Food Contaminant: Main Sources, Detection Levels, and Implications for Human and Public Health. Foods 2024, 13, 1697. [Google Scholar] [CrossRef]
  154. Meyer, A.; Santos, A.S.E.; Asmus, C.I.R.F.; Camara, V.M.; Costa, A.J.L.; Sandler, D.P.; Parks, C.G. Acute Kidney Failure among Brazilian Agricultural Workers: A Death-Certificate Case-Control Study. Int. J. Environ. Res. Public Health 2022, 19, 6519. [Google Scholar] [CrossRef]
  155. Nacano, B.R.M.; Convento, M.B.; Oliveira, A.S.; Castino, R.; Castino, B.; Razvickas, C.V.; Bondan, E.; Borges, F.T. Effects of glyphosate herbicide ingestion on kidney function in rats on a balanced diet. J. Bras. Nefrol. 2024, 46, e20230043. [Google Scholar] [CrossRef] [PubMed]
  156. Khacha-Ananda, S.; Intayoung, U.; Kohsuwan, K.; Wunnapuk, K. Exploring the link: DNA methylation and kidney injury markers in farmers exposed to glyphosate-surfactant herbicides. Regul. Toxicol. Pharmacol. 2025, 156, 105765. [Google Scholar] [CrossRef] [PubMed]
  157. Bonner, M.R.; Coble, J.; Blair, A.; Beane Freeman, L.E.; Hoppin, J.A.; Sandler, D.P.; Alavanja, M.C.R. Malathion Exposure and the Incidence of Cancer in the Agricultural Health Study. Am. J. Epidemiol. 2007, 166, 1023–1034. [Google Scholar] [CrossRef] [PubMed]
  158. Bogen, K.T.; Singhal, A. Malathion dermal permeability in relation to dermal load: Assessment by physiologically based pharmacokinetic modeling of in vivo human data. J. Environ. Sci. Heal. Part B 2016, 52, 138–146. [Google Scholar] [CrossRef]
  159. Albright, R.K.; Kram, B.W.; White, R.P. Malathion Exposure Associated With Acute Renal Failure. JAMA 1983, 250, 2469. [Google Scholar] [CrossRef]
  160. Yokota, K.; Fukuda, M.; Katafuchi, R.; Okamoto, T. Nephrotic syndrome and acute kidney injury induced by malathion toxicity. BMJ Case Rep. 2017, 2017, bcr2017220733. [Google Scholar] [CrossRef]
  161. Wan, E.-T.; Darssan, D.; Karatela, S.; Reid, S.A.; Osborne, N.J. Association of Pesticides and Kidney Function among Adults in the US Population 2001–2010. Int. J. Environ. Res. Public Health 2021, 18, 10249. [Google Scholar] [CrossRef]
  162. Lozano-Paniagua, D.; Parrón, T.; Alarcón, R.; Requena, M.; Lacasaña, M.; Hernández, A.F. Renal tubular dysfunction in greenhouse farmers exposed to pesticides unveiled by a panel of molecular biomarkers of kidney injury. Environ. Res. 2023, 238, 117200. [Google Scholar] [CrossRef]
  163. Vaziri, N.D.; Ness, R.L.; Fairshter, R.D.; Smith, W.R.; Rosen, S.M. Nephrotoxicity of paraquat in man. Arch. Intern. Med. 1979, 139, 172–174. [Google Scholar] [CrossRef]
  164. Asl, A.S.; Dadashzadeh, P. Acute kidney injury in patients with paraquat intoxication; a case report and review of the literature. J. Ren. Inj. Prev. 2016, 5, 203–206. [Google Scholar] [CrossRef]
  165. Mohamed, F.; Buckley, N.A.; Jayamanne, S.; Pickering, J.W.; Peake, P.; Palangasinghe, C.; Wijerathna, T.; Ratnayake, I.; Shihana, F.; Endre, Z.H. Kidney damage biomarkers detect acute kidney injury but only functional markers predict mortality after paraquat ingestion. Toxicol. Lett. 2015, 237, 140–150. [Google Scholar] [CrossRef]
  166. Weng, C.-H.; Chen, H.-H.; Hu, C.-C.; Huang, W.-H.; Hsu, C.-W.; Fu, J.-F.; Lin, W.-R.; Wang, I.-K.; Yen, T.-H. Predictors of acute kidney injury after paraquat intoxication. Oncotarget 2017, 8, 51345–51354. [Google Scholar] [CrossRef]
  167. Mohamed, F.; Endre, Z.; Jayamanne, S.; Pianta, T.; Peake, P.; Palangasinghe, C.; Chathuranga, U.; Jayasekera, K.; Wunnapuk, K.; Shihana, F.; et al. Mechanisms Underlying Early Rapid Increases in Creatinine in Paraquat Poisoning. PLoS ONE 2015, 10, e0122357. [Google Scholar] [CrossRef] [PubMed]
  168. Lebov, J.F.; Engel, L.S.; Richardson, D.; Hogan, S.L.; Sandler, D.P.; Hoppin, J.A. Pesticide exposure and end-stage renal disease risk among wives of pesticide applicators in the Agricultural Health Study. Environ. Res. 2015, 143, 198–210. [Google Scholar] [CrossRef] [PubMed]
  169. Lebov, J.F.; Engel, L.S.; Richardson, D.; Hogan, S.L.; Hoppin, J.A.; Sandler, D.P. Pesticide use and risk of end-stage renal disease among licensed pesticide applicators in the Agricultural Health Study. Occup. Environ. Med. 2015, 73, 3–12. [Google Scholar] [CrossRef] [PubMed]
  170. Abdul, K.; De Silva, P.M.C.; Ekanayake, E.; Thakshila, W.; Gunarathna, S.; Gunasekara, T.; Jayasinghe, S.; Asanthi, H.; Chandana, E.; Chaminda, G.; et al. Occupational Paraquat and Glyphosate Exposure May Decline Renal Functions among Rural Farming Communities in Sri Lanka. Int. J. Environ. Res. Public Health 2021, 18, 3278. [Google Scholar] [CrossRef]
  171. Stem, A.D.; Brindley, S.; Rogers, K.L.; Salih, A.; Roncal-Jimenez, C.A.; Johnson, R.J.; Newman, L.S.; Butler-Dawson, J.; Krisher, L.; Brown, J.M. Exposome and Metabolome Analysis of Sugarcane Workers Reveals Predictors of Kidney Injury. Kidney Int. Rep. 2024, 9, 1458–1472. [Google Scholar] [CrossRef]
  172. McGwin, G., Jr.; Griffin, R.L. An ecological study regarding the association between paraquat exposure and end stage renal disease. Environ. Health 2022, 21, 127. [Google Scholar] [CrossRef]
  173. Ornish, D. Holy Cow! What’s good for you is good for our planet: Comment on “Red Meat Consumption and Mortality”. Arch. Intern. Med. 2012, 172, 563–564. [Google Scholar] [CrossRef]
  174. Piccoli, G.B.; Cupisti, A.; Aucella, F.; Regolisti, G.; Lomonte, C.; Ferraresi, M.; Claudia, D.; Ferraresi, C.; Russo, R.; La Milia, V.; et al. Green nephrology and eco-dialysis: A position statement by the Italian Society of Nephrology. J. Nephrol. 2020, 33, 681–698. [Google Scholar] [CrossRef]
  175. van Vredendaal, O.P.; Bé, A.; de Barbieri, I.; Gallego, D.; Loud, F.; Piccoli, G.B.; Wieringa, F.; Vanholder, R. 2023 European Kidney Forum: The future of kidney care—investing in green nephrology to meet the European Green Deal targets. J. Nephrol. 2025, 38, 815–825. [Google Scholar] [CrossRef]
  176. Ye, J.J.; Wang, S.S.; Fang, Y.; Zhang, X.J.; Hu, C.Y. Ambient air pollution exposure and risk of chronic kidney disease: A systematic review of the literature and meta-analysis. Environ. Res. 2021, 195, 110867. [Google Scholar] [CrossRef]
  177. Xu, W.; Jia, L.; Lin, Y.; Zhang, C.; Sun, X.; Jiang, L.; Yao, X.; Wang, N.; Deng, H.; Wang, S.; et al. Association of air pollution and risk of chronic kidney disease: A systematic review and meta-analysis. J. Biochem. Mol. Toxicol. 2024, 38, e23610. [Google Scholar] [CrossRef]
Figure 1. Proposed mechanisms linking air pollution to kidney injury.
Figure 1. Proposed mechanisms linking air pollution to kidney injury.
Jcm 14 07278 g001
Table 1. Studies on the short-term exposure to air pollutants on chronic kidney injury.
Table 1. Studies on the short-term exposure to air pollutants on chronic kidney injury.
Short/Long-TermCountry/PopulationStudy DesignPollutantsHealth Effects-Major Findings
1. Fang et al. [80]Short-term71 participants/ChinalongitudinalPM2.5Significant changes in eGFR were associated with individual PM2.5 exposures.
2. Kuźma et al. [75]Long-term and short-term3554/PolandCross-sectionalPM2.5, PM10, NO2, and SO2.The odds of CKD increased with an increase in annual concentration of PM2.5.
3. Bi et al. [81]Short-term306,595 visits/USATime-series studyPM2.5, major PM2.5 components: elemental carbon, organic carbon, sulfate, nitrate, and gaseous co-pollutants (O3, CO, SO2, NO2, and NOx)Positive associations for most air pollutants, for acute renal failure, and positive associations particularly for 8-day exposure to OC, nitrate.
4. Gao et al. [82]Short-term2280 older male veterans/USACohortPM2.5, sulfurPositive relationships of PM2.5 mixture with serum uric acid and odds of CKD; sulfur was also associated with a 39% higher odds of CKD.
5. Lee et al. [83].Short-term902,043 cases/KoreaTime-series studyPM10, SO2, CO, O3For all kidney and urinary diseases (902,043 cases), excess ER visits attributable to air pollution existed for all pollutants studied. For AKI (76,330 cases), we estimated the highest impact on excess ER visits from O3, while for CKD (210,929 cases), the impacts of CO and SO2 were the highest.
6. Wu et al. [84].Short-term40,276 CKD-related hospital visits/ChinaTime-series studyNO2NO2 exposure and low temperature were associated with an increased risk of CKD-related hospital visits.
7. Cai et al. [85]Short-term101,919 deaths/Chinacase-crossover sPM1, PM2.5, PM10, O3, NO2, SO2, COAll air pollutants were associated with a percent increase in death from kidney disease.
8. Peng et al. [62].Long-term and short-termChina/2699Cross-sectionalOzone (O3)Long-term association between an increment of 3-year ozone exposure with decrease in eGFR, more pronounced in drinkers compared to non-drinkers in relation to ozone exposure.
9. Chu et al. [86]Short-term1,209,934 cases/USAcase-crossover studyPM2.5, NO2 and O3PM2.5 exposure associated with acute kidney failure, glomerular diseases, and acute kidney failure; no associations with O3 exposure.
10. Chen et al. [87]Short-term23,475 GN visits in years 2015–2019retrospectiveCO, NO2, PM10, PM2.5, SO2, and O3The risks for GN visits were positively associated with CO exposure.
11. Ma et al. [88]Short- and long-termChina/6958 PWHAs (people with HIV/AIDS)Cross-sectional PM1, PM2.5, PM10Short-term exposure to particulate matter was related to reduced renal function, mainly PM1, PM2.5, and PM10. Long-term exposure to PM1, PM2.5, and PM10 was positively linked with the incidence of CKD.
Table 2. Studies on long-term exposure to air pollutants on chronic kidney disease.
Table 2. Studies on long-term exposure to air pollutants on chronic kidney disease.
Country/PopulationStudy DesignPollutantsHealth Effects-Major Findings
1. Yang et al. [54]21,656/TaiwanCohortPM10, PM coarse, PM2.5An increase in PM10 and PMcoarse was negatively associated with eGFR and positively associated with the prevalence of CKD; neither outcome was significantly associated with PM2.5.
2. Bowe et al. [47]2,010,398/USACohortPM10, NO2, and CORise in PM10 and CO exposure related to increased risk of eGFR of less than 60 mL/min per 1.73 m2, incident chronic kidney disease, and increased risk of end-stage renal disease.
3. Bowe et al. [46]2,482,737 US veteranscohortPM2.5Increase in PM2.5 concentration was associated with increased risk of eGFR <60 mL/min per 1.73 m2, CKD, eGFR decline ≥ 30%, and ESRD.
4. Kim et al. [89]24,407/KoreacohortPM10, NO2, SO2, COIncreases in the annual mean concentrations of PM10 and NO2 were associated with decreases in eGFR levels; no statistically significant association between PM10 and NO2 concentration and the incidence of CKD.
5. Chen et al. [90]8,497 adults > 65/TaiwanCohortPM2.5, NO2Increments of PM2.5 exposure were associated with a lower eGFR.
6. Bragg-Gresham et al. [91]1,164,057 adults ≥ 65/USACross-sectional studyPM2.5Increase in PM2.5 concentration was associated with higher risk of CKD.
7. Chan et al. [92].100,629/TaiwanCohortPM2.5Rise in PM2.5 levels was associated with a higher risk of developing CKD.
8. Blum et al. [93]10,997/USAcohortPM2.5No significant PM2.5-eGFR association at baseline. Higher annual average PM2.5 exposure was associated with a significantly higher risk of incident CKD.
9. Wang et al. [94]3622/ChinaCross-sectionalPM10Increase in PM10 exposure was significantly associated with the increased prevalence of CKD.
10. Ran et al. [95]61,447/Hong KongCohortPM2.5Increase in PM2.5 concentration related to renal failure and mortality among patients with chronic kidney disease.
11. Lin et al. [96]161,970/TaiwancohortPM2.5, NO, SO2SO2, Nox, and NO exposure related to risk of developing CKD and risk of ESRD.
12. Lin et al. [97]6628 adult with CKD/TaiwancohortPM2.5PM2.5 exposure related to progression to KFRT (initiation of maintenance hemodialysis, peritoneal dialysis, or kidney transplantation), no evident association between PM2.5 and all-cause mortality.
13. Bo et al. [98].163,197/TaiwanCohortPM2.5Decrease in the ambient concentration of PM2.5 was associated with a 25% reduced risk of CKD development.
14.Feng et al. [99]820/BelgiumCross-sectional studyPM2.5, black carbonIn a population with moderate exposure, renal function was unrelated to ultrafine particulate.
15. Li et al. [100]47,204/ChinacohortPM2.5An increase in PM2.5 was positively associated with CKD prevalence and albuminuria.
16. Li et al. [101]80,225/ChinaCohortPM2.5, NO2, CO, O3, SO2An increase in CO and SO2 exposure positively associated with CKD. O3 exposure was not associated with CKD.
17. Jung et al. [102].29,602/KoreaCohortPM2.5, PM10, NO2, SO2, and COThe significant effects of PM2.5 and CO on mortality in CKD patients.
18. Paoin et al. [103]1839/ThailandCohortPM10, O3, NO2, SO2, COPM2.5, NH4+, NO3, OM BC, and SO42 exposures associated with risk of CKD.
19. Xu et al. [104]30,396/SwedenCohortPM2.5, PM10, NOx, BCPM10, NOx, and BC exposure were associated with significantly elevated risk for incident CKD; no significant associations with PM2.5.
20. Wu et al. [105]6480/TaiwanCohortPM2.5, NO2Increasing PM2.5 and NO2 level related to risk of eGFR deterioration.
21. Lee et al. [49]61,097,767/USACohortPM2.5, NO2Annual exposure in PM2.5 and NO2 related to risk of total kidney and urinary system disease.
22. Lin et al. [106]6716/TaiwancohortPM2.5, NO2, SO2High PM2.5 exposure related to significantly increased risk of CKD.
23. Ghazi et al. [107]20,289 without CKD/USACohortPM2.5Annual exposure to PM2.5 related to developing CKD.
24.Wu et al. [108]724 in 2020; 758 in 2019/CohortPM2.5In 2020, compared with 2019, reduction in the average PM2.5 concentration, and reduction in cumulative days with PM2.5 concentration >35 μg/m3. From 2019 to 2020, the yearly incidence of eGFR decline ≥5 mL/min/1.73 m2 decreased by 1/3. The proportion of patients who started dialysis decreased by 1/3 in 2020 (p = 0.001).
25. Oh et al. [109]15,983/Koreacross-sectional population-based studyPM2.5, PM10, NO2, and COAnnual exposure to PM2.5, PM10, NO2, and CO was significantly associated with decreased eGFR. Long-term exposure to PM2.5 and PM10 was associated with an increased risk of CKD.
26. Huh et al. [110]134,478 dialysis patients/KoreaCohortCOA significant association between CO exposure and all-cause mortality.
27. Liu et al. [111]2082/ChinaCohortPM2.5 and PM10PM2.5 and PM10 exposure was associated with an increased risk of CKD.
28. Liu et al. [112]90,032/ChinaCohortPM2.5, PM10, NO2, SO2, O3, COCombined air pollution associated with risk of CKD.
29. Duan et al. [113]13,472,425 without CKD/ChinaCohortPM2.5Greater long-term ambient PM2.5 pollution is associated with incident CKD.
30. Yang et al. [114]47,086/ChinaCross-sectional studyO3Rise O3 concentration was associated with risk of CKD prevalence.
31. Guo et al. [115]10,942/Taiwan, Hong KongCohortPM2.5, NO2 and O3PM2.5 exposure was associated with a reduction in the yearly increase in eGFR and a greater risk of incident CKD. Increase in NO2 exposure was associated with a higher risk of incident CKD.
32. Luo et al. [116]1979 patients with IgAN/ChinaCohortPM2.5PM2.5 exposure was associated with increased kidney failure risk (ESRD).
33. Chang et al. [117]5301 CKD patients/TaiwanCohortCO, NO, NO2, SO2, O3, PM2.5, and PM10Exposure to CO, NO, NO2, SO2, PM2.5, and PM10 associated with a significantly higher risk of renal progression.
34.Wang et al. [118]458,968/UKCohortPM2.5, PM10, NO2, and NOPM2.5, PM10, NO2, and NO exposure are associated with risk for CKD.
35. Hu et al. [119]5902/ChinaCohortPM2.5PM2.5 was associated with the risks of decline of kidney function.
36. Chen et al. [120]34,088/TaiwanCohortPM2.5Increase exposure of PM2.5 associated with higher mortality.
37. Wen et al. [64]8996/ChinaCross-sectional studyPM2.5, BC, NH4+, NO3, SO42−, OM, O3Long-term exposures to BC and OM were associated with eGFR decline, while O3, PM10, NH4+, and NO3 were associated with eGFR.
38. Su et al. [121]26,032 adult/TaiwanCohortPM2.5, PM10, CO, NO, NOx, SO2, and O3Elevated levels of PM2.5, PM10, O3, and SO2 were associated with a decreased eGFR, whereas higher levels of CO, NO, and NOx were associated with an increased eGFR.
39. Zhang et al. [65]2,938,653/Chinacross-sectional studyPM2.5 components: black carbon [BC], organic matter [OM], nitrate [NO3], ammonium [NH4+], sulfate [SO42−]PM2.5, NH4+, NO3, OM BC, and SO42 exposures associated with risk of CKD.
40. Li et al. [122]453,347/UK BiobankCohortPM2.5, PM2.5–10, PM10, NO2, and NOxIncrease in PM2.5, NO2, and NOx associated with an elevated risk of incident ESKD. An increased risk of all-cause mortality was associated with PM2.5 exposure.
41. Li et al. [63]367,978/UK BiobankCohortPM2.5 and PM10, nitrogen dioxide (NO2), nitrogen oxides (NOX)Moderate and high exposure to PM2.5, NO2, and NOX associated with risks of CKD.
42. Zhang et al. [123]6024 participants/ChinaCohortO3Ozone exposure was negatively associated with the eGFR.
43. Shang et al. [60]China/1738 patients with T2DM and CKDCohort retrospectiveO3, PM2.5, PM10, NO2, SO2 and COAssociation of PM2.5 and PM10, and CO and SO2 concentration with ESRD.
44. Zhang et al. [124]UK/40,513 diabetic patientsCohortPM2.5, PM10, PM2.5–10, NO2, and NOXMultiple air pollutants were positively associated with incident CKD in diabetic patients in the UK.
45. Peng S et al. [125]China/13,041CohortPM1, PM1–2.5 PM2.5, PM2.5–10 and PM10Increased risk of kidney disease was associated with PM1, PM1–2.5 PM2.5, PM2.5–10, and PM10 exposure.
46. Yang et al. [126]Chinacross-sectionalPM2.5 componentsSignificant associations between long-term exposure to three PM2.5 components [including black carbon (BC), sulfate (SO42−), and organic matter (OM)] and CKD prevalence. No association between [nitrate (NO3) or ammonium (NH4+)] with CKD prevalence.
47. Kim et al. [127]Korea/61,073CohortO3Long-term ambient O3 increases the risk of ESRD and mortality in CKD.
48. Hwang et al. [128]164,093/KoreaCohortPM10, SO2, NO2, CO, and O3Air pollutant exposures including PM10, SO2, NO2, CO, and O3 showed no significant association with incident CKD after adjustments for age, sex, household income, area of residence, and the Charlson comorbidity index.
49. Dai et al. [58]China/81,137CohortPM2.5 constituents—black carbon, ammonium, nitrate, sulfate, soil particles, sea saltPM2.5 constituents had positive correlations with CKD as well as black carbon, ammonium, nitrate, organic matter, sulfate, soil particles, and sea salt.
50. Chen R et al. [129]China/47,204Survey cross-sectionalPM1, PM2.5, PM1–2.5Rise in PM1 was related to a higher CKD risk and albuminuria (OR, 1.11; 95% CI, 1.05–1.17), but no significant relationship was found for PM1–2.5.
51. Dillon et al. [52]USA/7722Cross-sectional studyPM2.5, NO2, O3Positive associations between PM2.5, O3, and NO2 with CKD; NO2 was inversely associated.
52. Zhao et al. [130]992 T2D patients/TaiwanCohortPM2.5, NO2Patients exposed to PM2.5 and NO2 were found to have an increased risk of CKD occurrence.
53. Kadelbach et al. [78]Multicentre—Netherlands, Denmark, Austria, France/289,564cohortNO2, black carbon (BC), O3, PM2.5Associations between long-term exposure to air pollution and chronic kidney disease-associated mortality were positive for PM2.5, BC, NO2, and inverse for O3.
54. Nagai et al. [74]Japan/77,770cohortPM2.5Elevated PM2.5 did not represent a significant risk factor for incident CKD in Ibaraki prefecture in Japan.
55. Leonetti et al. [70]Thailand/analysis included 718,686 CKD-related deathsSpatial–temporal analysisPM2.5 (black carbon, organic carbon, dust, sulfate, and sea salt)Each 1 µg/m3 increase in PM2.5, black carbon, dust, sulfate, and organic carbon was significantly associated with increased CKD.
56. Yi et al. [70]Korea/1394 patients with glomerulonephritisretrospective cohortPM10, PM2.5, CO, and NO2Significant associations between elevated levels of PM10, PM2.5, CO, and NO2 with the progression of kidney disease (GFR < 60), as well as between PM10, PM2.5, and CO with lower eGFR.
57. Kilbo Edlund et al. [131]30,154/Swedencross-sectional analysisPM2.5, PM10, NOPM2.5 exposure was associated with 1.3% (95% CI 0.6, 2.0) higher eGFR per 2.03 µg/m3 (interquartile range, IQR). PM2.5 exposure was also associated with elevated serum matrix metalloproteinase 2 (MMP-2) concentration; increased filtration is an early sign of renal injury and may be related to the relatively healthy population at comparatively low exposure levels. Furthermore, PM2.5 exposure was associated with higher serum MMP-2, an early indicator of renal and cardiovascular pathology.
58.Chin et al. [132]992 T2D patients/TaiwanCohortPM2.5, NO2Patients exposed to PM2.5 and NO2 were found to have an increased risk of CKD occurrence.
Table 3. Studies on air pollution and acute kidney injury/acute kidney disease.
Table 3. Studies on air pollution and acute kidney injury/acute kidney disease.
Short/Long-TermCountry/PopulationStudy DesignPollutantsHealth Effects
1. Lee et al. [83]Short-term902,043 cases/KoreaTime-series studyPM10, SO2, CO, O3For all kidney and urinary disease, excess ER visits attributable to air pollution existed for all pollutants studied. For AKI, highest impact on excess ER visits from O3, while for CKD the impacts of CO and SO2 were the highest.
2. He et al. [79]Short-term11,293/ChinaCase-crossover studyPM2.5, PM10, CO, NO2, SO2, O3NO2 is associated with the risk of hospital-associated AKI.
3. Lee et al. [137]Long-term61,300,754/USAcohortPM2.5, NO2, and O3Exposure to PM2.5, NO2, and O3 was associated with increased risk for first hospital admission for AKI.
4. Lopez -Bueno et al. [140]Short-termMadrid/Spainretrospective studyPM10, PM2.5, NO2 and O3 Extreme heat exacerbates daily emergency hospital admissions due to kidney disease.
5. Min et al. [139]Short-term41,379 AKI-related deaths in 136 locations in 6 countries 1987–2018Case time-seriesPM2.5, O3, NO2AKI-related deaths related to PM2.5, warm-season O3, and NO2.
6. Liu et al. [141]Long-term414,885 UK Biobank (UKB) participantsCohortPM2.5, PM2.5–10, PM10, NO2, NOxHigher risks of AKI for each 5 microgram per cubic meter increase in PM2.5 and PM10, each 10 microgram per cubic meter increase in NO2 and NOx, respectively.
7. Min et al. [138]Short-termSouth Korea/160,390 incident AKI casesSpatial–temporal case-crossoverPM2.5, O3Short-term exposure to PM2.5 and O3 was associated with ED visits due to AKI. Incident Aki was associated with conjunction with ischemic heart disease, cerebrovascular disease, gastrointestinal bleeding, and pneumonia. For O3, relevance of AKI with ischemic heart disease.
8. Xiao et al. [142]Short- and long term 45,249 hospitalized patients/China case-crossover CO, PM2.5, PM2.5–10CO, PM2.5, and PM2.5–10 exposure related to significant increase in kidney failure hospitalization, in particular in cold seasons.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Małyszko, S.J.; Gryko, A.; Małyszko, J.; Jakubowska, Z.; Musiałowska, D.; Fabiańska, A.; Kuźma, Ł. Air Pollution, Kidney Injury, and Green Nephrology—Thinking About Its Association and Causation. J. Clin. Med. 2025, 14, 7278. https://doi.org/10.3390/jcm14207278

AMA Style

Małyszko SJ, Gryko A, Małyszko J, Jakubowska Z, Musiałowska D, Fabiańska A, Kuźma Ł. Air Pollution, Kidney Injury, and Green Nephrology—Thinking About Its Association and Causation. Journal of Clinical Medicine. 2025; 14(20):7278. https://doi.org/10.3390/jcm14207278

Chicago/Turabian Style

Małyszko, Sławomir Jerzy, Adam Gryko, Jolanta Małyszko, Zuzanna Jakubowska, Dominika Musiałowska, Anna Fabiańska, and Łukasz Kuźma. 2025. "Air Pollution, Kidney Injury, and Green Nephrology—Thinking About Its Association and Causation" Journal of Clinical Medicine 14, no. 20: 7278. https://doi.org/10.3390/jcm14207278

APA Style

Małyszko, S. J., Gryko, A., Małyszko, J., Jakubowska, Z., Musiałowska, D., Fabiańska, A., & Kuźma, Ł. (2025). Air Pollution, Kidney Injury, and Green Nephrology—Thinking About Its Association and Causation. Journal of Clinical Medicine, 14(20), 7278. https://doi.org/10.3390/jcm14207278

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop